≡ Risteys
FG R12 + FR

Documentation Changelog GitHub Contact & Feedback

Chronic iridocyclitis

DOID EFO Endpoint Browser PheWeb

H7_IRIDOCHRONIC

Endpoint definition

↥

Endpoint definition steps

FinnGen

Phenotype data

520210

1. Apply sex-specific rule

None

520210

2. Check conditions

None

520210

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Hospital discharge: ICD-10 — H20.1
  • Hospital discharge: ICD-9 — 3641
  • Hospital discharge: ICD-8 — 36402
  • Cause of death: ICD-10 — H20.1
  • Cause of death: ICD-9 — 3641
  • Cause of death: ICD-8 — 36402

2 out of 7 registries used, show all original rules.

1940

4. Check minimum number of events

None

1940

5. Include endpoints

None

1940

6. Filter based on genotype QC (FinnGen only)

1940

Control definitions (FinnGen only)

Control exclude
H7_SCLERACORNEA

Extra metadata

Level in the ICD hierarchy
5
First used in FinnGen datafreeze
DF2
Parent code in ICD-10
H20
Name in latin
Iridocyclitis chronica

Case counts by codes

↥

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

All Female Male
Number of individuals
Whole population 13764 7914 5767
Only index persons 12320 7123 5197
Unadjusted period prevalence (%)
Whole population 0.20 0.23 0.16
Only index persons 0.24 0.26 0.20
Median age at first event (years)
Whole population 49.41 51.00 47.22
Only index persons 48.33 49.76 46.36

-FinnGen-

Key figures

All Female Male
Number of individuals 1940 1192 748
Unadjusted period prevalence (%) 0.38 0.41 0.33
Median age at first event (years) 49.90 48.77 51.71

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
1786
Matched controls
17858
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
H20.1
ICD-10 Finland
Chronic iridocyclitis
+∞
323.0
1664
*
Z96.1
ICD-10 Finland
Presence of intraocular lens
11.6
323.0
693
922
202
Kela drug reimbursment
Connective tissue diseases, rheumatoid arthritis and comparable disease
12.1
323.0
752
1015
S01BA04
ATC
prednisolone; ophthalmic (corticosteroids, plain)
76.5
323.0
440
76
S01BA01
ATC
dexamethasone; ophthalmic (corticosteroids, plain)
32.8
323.0
487
202
H20.0
ICD-10 Finland
Acute and subacute iridocyclitis
8121.9
323.0
1311
6
S01ED51
ATC
timolol, combinations; ophthalmic
22.9
323.0
641
425
H40.5
ICD-10 Finland
Glaucoma secondary to other eye disorders
150.8
319.2
332
27
S01ED01
ATC
timolol; ophthalmic
26.8
298.4
423
204
L04AX03
ATC
methotrexate; systemic (immunosuppressants)
10.7
282.8
609
820
114
Kela drug reimbursment
Glaucoma
11.8
256.8
515
591
S01EA05
ATC
brimonidine; ophthalmic (sympathomimetics in glaucoma therapy)
41.2
240.1
303
88
S01EC01
ATC
acetazolamide; systemic
37.5
235.8
304
97
S01CA02
ATC
prednisolone and antiinfectives; ophthalmic (ophth., corticosteroids and antiinfectives in comb.)
84.2
233.5
260
36
S01CA01
ATC
dexamethasone and antiinfectives; ophthalmic (ophth., corticosteroids and antiinfectives in comb.)
5.3
226.1
1011
3548
S01FA04
ATC
cyclopentolate; ophthalmic
119.8
223.5
239
23
S01XA20
ATC
artificial tears and other indifferent preparations; ophthalmic
5.1
221.3
1130
4538
Z01.0
ICD-10 Finland
Examination of eyes and vision
6.5
219.3
688
1569
CJE20
NOMESCO Finland
Phakoemulsification with implantation of artificial lens in posterior chamber
5.1
202.4
856
2728
M45
ICD-10 Finland
Ankylosing spondylitis
31.4
201.2
271
101
XCW99
NOMESCO Finland
Other investigative procedure of eye
7.3
188.8
512
927
S01BA07
ATC
fluorometholone; ophthalmic (corticosteroids, plain)
33.2
188.4
250
87
H20.9
ICD-10 Finland
Iridocyclitis, unspecified
403.5
185.3
183
5
H26.2
ICD-10 Finland
Complicated cataract
45.9
180.1
222
55
313
Kela drug reimbursment
Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab, tocilizumab and ustekinumab (rheumatoid diseases)
17.0
173.0
285
197
H02AB06
ATC
prednisolone; systemic
4.1
170.3
1185
5780
S01BC03
ATC
diclofenac; ophthalmic
19.8
167.6
260
152
A07EC01
ATC
sulfasalazine; oral, rectal
7.4
162.2
429
732
S01EC04
ATC
brinzolamide; ophthalmic
17.0
156.8
258
176
S01EE01
ATC
latanoprost; ophthalmic
10.0
146.2
311
368
H40.4
ICD-10 Finland
Glaucoma secondary to eye inflammation
1518.2
144.8
139
*
CK2X4
NOMESCO Finland
Optical coherence tomography (OCT) of ocular fundus
7.0
143.6
391
685
281
Kela drug reimbursment
Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab and tocilizumab
14.6
141.3
247
194
H30.2
ICD-10 Finland
Posterior cyclitis
304.7
139.5
140
5
H40.0
ICD-10 Finland
Glaucoma suspect
7.7
138.8
350
546
L01BA01
ATC
methotrexate; systemic (folic acid analog.)
10.8
136.3
277
299
S01FA02
ATC
scopolamine; ophthalmic
70.6
135.5
155
24
XCK00
NOMESCO Finland
Perimetry
8.2
132.5
320
465
L04AB04
ATC
adalimumab; parenteral
18.8
130.3
205
122
WX140
NOMESCO Finland
Parabulbar anesthesy
11.5
126.7
248
247
36402
ICD-8 Finland
Iritis, Iridocyclitis, uveitis chronica
+∞
124.4
118
*
H26.4
ICD-10 Finland
After-cataract
6.5
123.2
355
661
CJB10
NOMESCO Finland
Laser discission of secondary cataract
7.0
123.1
333
569
XCK10
NOMESCO Finland
Photography of fundus of eye
5.5
114.9
383
849
CHD50
NOMESCO Finland
Shunt operation on anterior chamber
1113.4
108.6
105
*
S01EA03
ATC
apraclonidine; ophthalmic
41.9
108.5
136
35
NK4XE
NOMESCO Finland
Joint ultrasound examination not elsewhere classified
6.3
106.7
311
580
H16.0
ICD-10 Finland
Corneal ulcer
18.4
102.6
162
96
M08.4
ICD-10 Finland
Pauciarticular juvenile arthritis
55.3
100.1
119
23
3641A
ICD-9 Finland
Disorders of iris and ciliary body, Chronic iridocyclitis
+∞
94.6
90
*
TCA20
NOMESCO Finland
Peribulbar therapeutic injection into orbit
945.6
92.7
90
*
TNX10
NOMESCO Finland
Arthrocentesis, unspecified region, unspecified region
5.8
92.6
287
572
H26.3
ICD-10 Finland
Drug-induced cataract
45.8
91.1
112
26
TCF00
NOMESCO Finland
Subconjunctival therapeutic injection
923.5
90.6
88
*
H25.1
ICD-10 Finland
Senile nuclear cataract
3.3
88.1
565
2217
S01BC05
ATC
ketorolac; ophthalmic
9.4
86.4
187
220
H04.10
ICD-10 Finland
Dry eye syndrome
4.7
86.3
327
813
36400
ICD-8 Finland
Iritis, Iridocyclitis acuta
+∞
86.1
82
*
S01EE03
ATC
bimatoprost; ophthalmic
16.6
85.5
140
91
S01EE05
ATC
tafluprost; ophthalmic
10.7
84.7
170
174
M08.3
ICD-10 Finland
Juvenile polyarthritis (seronegative)
53.4
84.5
101
20
CK2S4
NOMESCO Finland
Plain photography of ocular fundus
6.5
84.3
236
411
WX100
NOMESCO Finland
Conjunctival surface anesthesia
4.6
84.2
327
832
H15.1
ICD-10 Finland
Episcleritis
82.7
84.0
94
12
S01EC03
ATC
dorzolamide; ophthalmic
19.2
76.9
119
66
L04AX01
ATC
azathioprine; systemic
6.7
75.8
204
335
H22.1*M45
ICD-10 Finland
Iridocyclitis in ankylosing spondylitis
+∞
75.5
72
*
GD1AA
NOMESCO Finland
Thorax X-ray examination
2.5
72.6
889
5056
CKD65
NOMESCO Finland
Pars plana or pars plicata vitrectomy
12.0
71.2
134
120
CHF05
NOMESCO Finland
Transscleral laser coagulation of ciliary body
113.3
70.4
76
7
H02AB07
ATC
prednisone; oral
3.4
69.2
383
1312
H20.8
ICD-10 Finland
Other iridocyclitis
+∞
69.2
66
*
S01EC54
ATC
brinzolamide, combinations; ophthalmic
22.7
69.1
101
47
H35.39
ICD-10 Finland
Degeneration of macula and posterior pole
9.1
68.9
151
180
L88
ICPC
Rheumatoid/seropositive arthritis
7.0
68.8
179
279
XCH00
NOMESCO Finland
Eye pressure measurement
7.4
67.7
169
248
M08.0
ICD-10 Finland
Juvenile rheumatoid arthritis
34.2
67.4
88
27
CKD05
NOMESCO Finland
Puncture of vitreous body with injection of medication
6.6
67.0
182
301
3640A
ICD-9 Finland
Disorders of iris and ciliary body, Acute and subacute iridocyclitis
+∞
62.9
60
*
S01EE04
ATC
travoprost; ophthalmic
12.2
60.4
112
97
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
2.4
59.2
674
3571
H33.0
ICD-10 Finland
Retinal detachment with retinal break
8.2
58.8
137
180
S01FA01
ATC
atropine; ophthalmic
38.5
58.3
74
20
H40.13
ICD-10 Finland
Chronic glaucoma with open ventricular angle
6.3
58.2
163
280
H26.02
ICD-10 Finland
Presenil cataract
8.9
57.2
126
151
H20
ICD-10 Finland
Iridocyclitis
91.7
56.2
62
7
M46.9
ICD-10 Finland
Inflammatory spondylopathy, unspecified
18.6
55.9
87
49
H21.1
ICD-10 Finland
Other vascular disorders of iris and ciliary body
+∞
54.4
52
*
H57.1
ICD-10 Finland
Ocular pain
7.9
53.7
127
171
D86.8
ICD-10 Finland
Sarcoidosis of other and combined sites
27.1
52.9
73
28
P01BA02
ATC
hydroxychloroquine; oral
3.7
51.4
248
748
L04AA01
ATC
[U] ciclosporin; systemic
12.4
49.1
90
76
CS444
NOMESCO Finland
Visual field testing with Octopus automated perimetry
6.7
48.4
128
203
S01AD03
ATC
aciclovir; ophthalmic
7.4
48.4
119
170
H19.1*B00.5
ICD-10 Finland
Herpesviral keratoconjunctivitis
+∞
47.1
45
*
H40.10
ICD-10 Finland
Capsular glaucoma with pseudoexfoliation on the anterior lens capsule
8.3
46.1
105
133
H16.9
ICD-10 Finland
Keratitis, unspecified
164.3
46.0
48
*
S01EX03
ATC
NA
10.8
45.5
89
86
L04AA13
ATC
leflunomide; oral
7.0
44.6
114
172
CHD65
NOMESCO Finland
Nonpenetrating glaucoma surgery
29.5
44.6
60
21
7200A
ICD-9 Finland
Ankylosing spondylitis and other inflammatory spondylopathies, Ankylosing spondylitis
65.5
44.4
51
8
H22.1*D86.8
ICD-10 Finland
Iridocyclitis in sarcoidosis
+∞
43.9
42
*
ZXA00
NOMESCO Finland
Right side
2.2
43.5
538
2872
CKD40
NOMESCO Finland
Endophotocoagulation of retina
12.5
42.8
78
65
L04AB01
ATC
etanercept; parenteral
8.9
42.3
92
108
L04AA11
ATC
[U] etanercept; parenteral
34.1
40.8
53
16
H21.0
ICD-10 Finland
Hyphaema
+∞
40.8
39
*
D86.9
ICD-10 Finland
Sarcoidosis, unspecified
19.4
40.7
62
33
A02BC02
ATC
pantoprazole; systemic
2.0
40.3
1172
8767
ZXA10
NOMESCO Finland
Bilateral
2.4
39.2
388
1841
H22.1
ICD-10 Finland
Iridocyclitis in other diseases classified elsewhere
395.8
39.2
39
*
L04AB06
ATC
golimumab; parenteral
14.2
39.0
67
49
ZXA05
NOMESCO Finland
Left side
2.2
38.6
497
2678
NA6BG
NOMESCO Finland
Sacro-iliac joint MRI examination with high intensity magnet
10.8
38.5
75
72
3663A
ICD-9 Finland
Cataract secondary to ocular disorders
64.4
38.2
44
7
S01FA06
ATC
tropicamide; ophthalmic
73.2
38.1
43
6
L04AD01
ATC
ciclosporin; systemic
7.9
38.0
89
118
H10.3
ICD-10 Finland
Acute conjunctivitis, unspecified
3.9
37.9
165
452
H40.9
ICD-10 Finland
Glaucoma, unspecified
10.5
37.0
73
72
ZX120
NOMESCO Finland
Intravenous
3.0
36.8
236
869
CHC05
NOMESCO Finland
Iridotomy
10.7
36.7
72
70
S01ED02
ATC
betaxolol; ophthalmic
14.6
36.6
62
44
D86.0
ICD-10 Finland
Sarcoidosis of lung
11.2
36.6
70
65
M13.9
ICD-10 Finland
Arthritis, unspecified
3.5
36.3
184
571
M46.1
ICD-10 Finland
Sacroiliitis, not elsewhere classified
9.7
35.4
73
78
L04AA17
ATC
[U] adalimumab; parenteral
24.5
35.4
50
21
H35.36
ICD-10 Finland
Macular cyst
21.8
34.9
51
24
H11.3
ICD-10 Finland
Conjunctival haemorrhage
4.9
34.9
119
257
H40.8
ICD-10 Finland
Other glaucoma
125.9
34.8
37
*
CKD91
NOMESCO Finland
Extended vitrectomy through pars plana
10.5
34.5
68
67
CHD99
NOMESCO Finland
Other filtering operation
51.1
33.6
40
8
H35.38
ICD-10 Finland
Preretinal fibrosis of the macula
5.7
33.6
100
185
NK6QA
NOMESCO Finland
Measurement of bone density from tow or more locations with X-ray
3.5
32.6
165
511
H43.1
ICD-10 Finland
Vitreous haemorrhage
6.3
31.7
87
145
CHB10
NOMESCO Finland
Puncture of anterior chamber of eye with irrigation
37.1
31.6
40
11
S01EB01
ATC
pilocarpine; ophthalmic
21.4
31.4
46
22
H221, M084
ICD-10 Finland
NA
+∞
31.3
30
*
CS5Z4
NOMESCO Finland
Specialised imaging for glaucoma
7.6
31.1
74
101
CKD20
NOMESCO Finland
Removal of vitreous body substitute
22.5
30.5
44
20
H15.0
ICD-10 Finland
Scleritis
+∞
30.3
29
*
D86.2
ICD-10 Finland
Sarcoidosis of lung with sarcoidosis of lymph nodes
14.3
29.4
50
36
CKD15
NOMESCO Finland
Injection of vitreous substitute
25.5
28.8
40
16
H25.8
ICD-10 Finland
Other senile cataract
2.7
28.8
211
839
M01CB01
ATC
sodium aurothiomalate; parenteral
7.8
28.7
67
89
71200
ICD-8 Finland
Rheumatoid arthritis and allied conditions, Juvenile rheumatoid arthritis
29.8
28.6
38
13
TCG10
NOMESCO Finland
Removal of sutures from cornea
39.7
28.1
35
9
WX002
NOMESCO Finland
Sedation and analgesia
2.1
27.9
372
1994
H18.8
ICD-10 Finland
Other specified disorders of cornea
285.8
27.8
28
*
M05.8
ICD-10 Finland
Other seropositive rheumatoid arthritis
3.3
27.3
142
449
71240
ICD-8 Finland
Rheumatoid arthritis and allied conditions, Spondylitis ankylopoietica
54.2
27.2
32
6
L04AB05
ATC
certolizumab pegol; parenteral
17.2
26.7
42
25
CS494
NOMESCO Finland
Other visual field testing
6.3
26.7
72
118
H40.20
ICD-10 Finland
Acute glaucoma with closed ventricular angle
26.2
26.2
36
14
CKD10
NOMESCO Finland
Insufflation of vitreous cavity
6.8
26.2
67
102
3626
FHL
Extracapsular cataract surgery and implantation of an artificial lens
8.6
26.1
57
68
H18.1
ICD-10 Finland
Bullous keratopathy
+∞
26.1
25
*
37520
ICD-8 Finland
Glaucoma, Secondary
61.0
26.0
30
5
Z94.7
ICD-10 Finland
Corneal transplant status
264.3
25.8
26
*
CKD92
NOMESCO Finland
Combined vitrectomy and retinal procedure
9.5
25.3
52
56
NA6AA
NOMESCO Finland
Sacro-iliac joint X-ray examination
18.5
24.8
38
21
H16.2
ICD-10 Finland
Keratoconjunctivitis
253.5
24.7
25
*
CKD70
NOMESCO Finland
Excision of preretinal or epiretinal membrane
6.8
24.3
62
94
7143D
ICD-9 Finland
Rheumatoid arthritis and other inflammatory polyarthropathies, Juvenile chronic polyarthritis[OLIGARTHRITIS JUVENILIS]
56.8
24.1
28
5
NF1AE
NOMESCO Finland
Hip joint ultrasound examination
4.9
23.8
79
166
M08.9
ICD-10 Finland
Juvenile arthritis, unspecified
31.5
23.7
31
10
H19.1
ICD-10 Finland
Herpesviral keratitis and keratoconjunctivitis
243.1
23.7
24
*
H221, M083
ICD-10 Finland
NA
+∞
23.0
22
*
CS3P4
NOMESCO Finland
Optic nerve head stereophotography
10.5
22.6
44
43
H27.0
ICD-10 Finland
Aphakia
32.7
22.4
29
9
3656F
ICD-9 Finland
Glaucoma associated with other ocular disorders[GLAUCOMA POST UVEITIDEM]
+∞
21.9
21
*
M05BA04
ATC
alendronic acid; oral
2.6
21.8
163
653
H40.6
ICD-10 Finland
Glaucoma secondary to drugs
81.1
21.7
24
*
CHD05
NOMESCO Finland
Selective lasertrabeculoplasty
4.9
21.7
72
152
CG2S4
NOMESCO Finland
Photography of cornea
222.6
21.6
22
*
CKC12
NOMESCO Finland
Photocoagulation of retina
3.5
21.6
105
315
CKD93
NOMESCO Finland
Extended combined procedure on vitreous body and retina
19.1
21.3
32
17
132
Kela drug reimbursment
Sarcoidosis
11.0
21.2
40
37
SPAT1009
SPAT
Measurement of intraocular pressure
7.7
21.1
49
65
CHD15
NOMESCO Finland
Trabeculectomy and iridectomy
15.7
21.1
34
22
J05AB01
ATC
aciclovir; systemic
1.9
21.0
377
2235
H30.9
ICD-10 Finland
Chorioretinal inflammation, unspecified
60.8
20.9
24
*
4AA12
NOMESCO Finland
NA
18.1
20.9
32
18
F01
ICPC
Eye pain
4.5
20.9
75
172
H25.0
ICD-10 Finland
Senile incipient cataract
3.0
20.6
122
421
TCW99
NOMESCO Finland
Other minor procedure in eye surgery
6.8
19.9
50
75
CS1H4
NOMESCO Finland
Retinal nerve fibre layer imaging
7.6
19.7
46
62
M06.9
ICD-10 Finland
Rheumatoid arthritis, unspecified
3.8
19.7
86
237
4AB02
NOMESCO Finland
NA
16.6
19.6
31
19
T85.2
ICD-10 Finland
Mechanical complication of intraocular lens
21.9
19.5
28
13
37403
ICD-8 Finland
Cataract, Complicata
+∞
18.8
18
*
WX142
NOMESCO Finland
Sub-tenon anesthesy
13.6
18.7
32
24
J01FF01
ATC
clindamycin; systemic
1.7
18.7
463
3033
CHD35
NOMESCO Finland
Laser goniopuncture
24.0
18.6
26
11
H18.2
ICD-10 Finland
Other corneal oedema
101.1
18.6
20
*
CKA10
NOMESCO Finland
Biopsy of vitreous body
101.1
18.6
20
*
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
1.7
18.6
479
3171
TNG10
NOMESCO Finland
Puncture of knee
7.1
18.4
45
65
H54.2
ICD-10 Finland
Moderate visual impairment, binocular
9.7
18.4
37
39
A02BC03
ATC
lansoprazole; oral
1.7
18.2
487
3255
CKD60
NOMESCO Finland
Anterior vitrectomy
12.5
18.1
32
26
SPAT1263
SPAT
Sampling
1.6
18.1
711
5261
CKC15
NOMESCO Finland
Panretinal photocoagulation
9.6
17.9
36
38
TCH12
NOMESCO Finland
Sample aspiration from anterior chambre
+∞
17.7
17
*
S01FB01
ATC
phenylephrine; ophthalmic (sympathomimetics excl. antiglaucoma prep.)
+∞
17.7
17
*
H40.3
ICD-10 Finland
Glaucoma secondary to eye trauma
37.1
17.6
22
6
H30.1
ICD-10 Finland
Disseminated chorioretinal inflammation
181.7
17.5
18
*
S01EA02
ATC
dipivefrine; ophthalmic
21.1
17.3
25
12
H43.8
ICD-10 Finland
Other disorders of vitreous body
2.4
17.3
155
684
208
Kela drug reimbursment
Ulcerative colitis and Crohn's disease
3.0
17.2
104
366
K07.65
ICD-10 Finland
Temporomandibular joint-pain-dysfunction syndrome
9.9
17.2
34
35
D86.1
ICD-10 Finland
Sarcoidosis of lymph nodes
13.4
17.0
29
22
H3603, E103
ICD-10 Finland
NA
9.1
16.9
35
39
XCD20
NOMESCO Finland
Photoangiography of eye
5.6
16.8
49
90
H20.2
ICD-10 Finland
Lens-induced iridocyclitis
+∞
16.7
16
*
3656X
ICD-9 Finland
Glaucoma associated with other ocular disorders[GLAUCOMA SECUNDARIA ALIA SEU NUD]
171.5
16.5
17
*
3708
FHL
Trabeculectomy or equivalent
171.5
16.5
17
*
NK5AT
NOMESCO Finland
Joint injection with ultrasound guidance not elsewhere classified
9.6
16.4
33
35
GD1DD
NOMESCO Finland
High resolution CT examination of lungs
3.0
16.4
94
320
S01AX11
ATC
[U] ofloxacin; ophthalmic
3.5
16.1
77
230
Z01.8
ICD-10 Finland
Other specified special examinations
1.7
16.0
357
2250
H01.0
ICD-10 Finland
Blepharitis
2.7
15.9
109
413
K07.60
ICD-10 Finland
Snapping jaw
2.8
15.8
105
392
7143C
ICD-9 Finland
Rheumatoid arthritis and other inflammatory polyarthropathies, Juvenile chronic polyarthritis[POLYARTHRITIS JUVENILIS SERONEGATIVA]
33.7
15.7
20
6
CHD00
NOMESCO Finland
Laser trabeculoplasty
6.6
15.7
40
62
H30.8
ICD-10 Finland
Other chorioretinal inflammations
+∞
15.6
15
*
CFW99
NOMESCO Finland
Other operation on conjunctiva
26.5
15.6
21
8
CS434
NOMESCO Finland
Visual field testing with Humphrey automated perimetry
4.8
15.6
52
112
H18.4
ICD-10 Finland
Corneal degeneration
161.3
15.5
16
*
ZXC20
NOMESCO Finland
Use of chemical agents
5.0
15.4
49
100
H40
ICD-10 Finland
Glaucoma
8.0
15.3
34
43
TNH11
NOMESCO Finland
Injection of diagnostic or therapeutic substance in ankle joint or foot joint
5.9
15.3
42
72
XX9XE
NOMESCO Finland
Other ultrasound examination
6.4
15.1
39
62
NA3AA
NOMESCO Finland
Lumbar spine X-ray examination without contrast
2.2
15.0
167
815
S01BA09
ATC
clobetasone; ophthalmic
57.2
14.8
17
*
3793A
ICD-9 Finland
Other disorders of eye, Aphakia and other disorders of lens[APHAKIA]
57.2
14.8
17
*
CG2X4
NOMESCO Finland
Optical coherence tomography (OCT) of cornea
16.6
14.8
23
14
NA1EA
NOMESCO Finland
Cervical spine X-ray examination with flexion
5.2
14.7
45
88
CKC10
NOMESCO Finland
Local photocoagulation of retina
4.8
14.6
48
102
H44.1
ICD-10 Finland
Other endophthalmitis
80.8
14.6
16
*
K51.9
ICD-10 Finland
Ulcerative colitis, unspecified
3.5
14.5
67
195
J01DB01
ATC
cefalexin; oral
1.6
14.4
1373
12149
XCD10
NOMESCO Finland
Electrophysiological examination of eye
3.7
14.3
62
171
TCG00
NOMESCO Finland
Protection of cornea and sclera with soft lens
27.4
14.3
19
7
A02BA02
ATC
ranitidine; systemic
1.7
14.1
318
2004
R91
ICD-10 Finland
Abnormal findings on diagnostic imaging of lung
2.1
13.8
157
775
M08.1
ICD-10 Finland
Juvenile ankylosing spondylitis
53.8
13.8
16
*
S01GX01
ATC
cromoglicic acid; ophthalmic
1.7
13.8
332
2132
CKC70
NOMESCO Finland
Circular buckling of sclera
20.2
13.8
20
10
A02BC01
ATC
omeprazole; systemic
1.6
13.7
433
2991
WZB00
NOMESCO Finland
Telephone receipt or other advice
1.6
13.6
475
3360
WZA10
NOMESCO Finland
Long statement of health and health related matters
4.9
13.6
44
92
CG2T4
NOMESCO Finland
Topography assessment of cornea
12.1
13.6
24
20
CGG45
NOMESCO Finland
Full thickness transplantation of cornea using homograft
+∞
13.6
13
*
H17.9
ICD-10 Finland
Corneal scar and opacity, unspecified
+∞
13.6
13
*
L04AA06
ATC
mycophenolic acid; systemic
4.7
13.5
45
97
H33.3
ICD-10 Finland
Retinal breaks without detachment
3.1
13.5
75
251
M06.0
ICD-10 Finland
Seronegative rheumatoid arthritis
3.3
13.5
67
207
ND2AA
NOMESCO Finland
Hand and fingers X-ray examination
2.1
13.4
154
763
TPH04
NOMESCO Finland
Cathetrisation of vein
1.6
13.2
345
2265
A04AA01
ATC
ondansetron; systemic, rectal
2.3
13.1
120
536
TNX00
NOMESCO Finland
Puncture and needle biopsy of soft tissue, unspecified region
4.4
13.1
47
110
CJF30
NOMESCO Finland
Reduction of dislocation of artificial lens
28.6
13.0
17
6
WX408
NOMESCO Finland
General anesthesy, balanced
1.6
12.9
425
2959
UJF32
NOMESCO Finland
Coloscopy
1.6
12.9
400
2747
M02.9
ICD-10 Finland
Reactive arthropathy, unspecified
5.0
12.8
40
81
M01AH01
ATC
celecoxib; oral (coxibs)
1.7
12.7
285
1792
M25.5
ICD-10 Finland
Pain in joint
1.5
12.6
455
3234
CS424
NOMESCO Finland
Visual field testing with Goldmann perimetry
7.9
12.6
28
36
H22.0*B00.5
ICD-10 Finland
Herpesviral iridocyclitis
+∞
12.5
12
*
36409
ICD-8 Finland
Iritis, Unspecified
+∞
12.5
12
*
H44.4
ICD-10 Finland
Hypotony of eye
130.9
12.4
13
*
A07EC02
ATC
mesalazine; oral, rectal
2.4
12.3
104
445
S01BC01
ATC
indometacin; ophthalmic
37.8
12.2
15
*
H54.4
ICD-10 Finland
Blindness, monocular
16.0
12.1
19
12
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
1.5
12.1
569
4284
D86.3
ICD-10 Finland
Sarcoidosis of skin
18.2
12.0
18
10
H30.0
ICD-10 Finland
Focal chorioretinal inflammation
26.9
12.0
16
6
NF1AA
NOMESCO Finland
Hip X-ray examination
2.1
12.0
139
691
NH3EA
NOMESCO Finland
Feet X-ray examination with load
3.7
12.0
51
140
TNG11
NOMESCO Finland
Injection of diagnostic or therapeutic substance in knee
6.0
12.0
32
54
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
2.0
11.7
152
795
3643
FHL
Vitrectomy through pars Plana
30.2
11.6
15
5
R5110
NOMESCO Finland
Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it
1.8
11.6
191
1089
H36.03
ICD-10 Finland
Proliferative diabetic retinopathy
7.2
11.5
27
38
H57.9
ICD-10 Finland
Disorder of eye and adnexa, unspecified
7.2
11.5
27
38
H40.22
ICD-10 Finland
Chronic glaucoma with closed ventricular angle
9.3
11.5
23
25
NA2AA
NOMESCO Finland
Thoracal spine X-ray examination without contrast
3.5
11.5
53
156
NA1AA
NOMESCO Finland
Cervical spine X-ray examination without contrast
3.0
11.4
65
220
J05AB11
ATC
valaciclovir; oral
1.8
11.4
205
1199
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
1.5
11.3
521
3895
J01FA10
ATC
azithromycin; systemic
1.4
11.2
953
8002
NH3DA
NOMESCO Finland
Bilateral foot X-ray examination
3.6
11.2
49
138
XCH05
NOMESCO Finland
Eye pressure longterm registration
6.8
11.1
27
40
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
1.8
11.1
215
1290
Z03.9
ICD-10 Finland
Observation for suspected disease or condition, unspecified
1.6
11.1
276
1782
N02AX02
ATC
tramadol; systemic, rectal
1.4
11.0
641
5016
CKD94
NOMESCO Finland
Combined vitrectomy and procedure on lens through pars plana
4.9
11.0
35
73
CA1CG
NOMESCO Finland
Eye and orbita extensive MRI examination with high intensity magnet
6.3
10.9
28
45
CKC30
NOMESCO Finland
Cryopexy of detached retina
7.8
10.9
24
31
J18.9
ICD-10 Finland
Pneumonia, unspecified
1.6
10.9
340
2329
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
1.4
10.9
647
5080
3610A
ICD-9 Finland
Retinal detachments and defects, Retinal detachment with retinal defect
15.6
10.8
17
11
H3603, E113
ICD-10 Finland
NA
7.2
10.8
25
35
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
2.1
10.7
121
595
CFD10
NOMESCO Finland
Repair of conjunctiva
21.6
10.7
15
7
W01
ICD-10 Finland
Fall on same level from slipping, tripping and stumbling
1.5
10.6
437
3183
NH3AA
NOMESCO Finland
Foot and toes X-ray examination
2.0
10.5
143
760
CJF20
NOMESCO Finland
Removal of artificial lens
110.6
10.4
11
*
H44.0
ICD-10 Finland
Purulent endophthalmitis
110.6
10.4
11
*
H44.5
ICD-10 Finland
Degenerated conditions of globe
110.6
10.4
11
*
3632A
ICD-9 Finland
Chorioretinal inflammations and scars and other disorders of choroid, Other and unspecified forms of chorioretinitis and retinochoroiditis
+∞
10.4
10
*
UJF30
NOMESCO Finland
Ileoscopy through colon
1.9
10.4
156
860
H34.8
ICD-10 Finland
Other retinal vascular occlusions
3.8
10.4
43
116
H33.2
ICD-10 Finland
Serous retinal detachment
16.1
10.3
16
10
NH1AA
NOMESCO Finland
Ankle X-ray examination without contrast
2.1
10.3
110
530
CKD95
NOMESCO Finland
Extended combined vitectomy and lens procedure through pars plana
12.1
10.3
18
15
H46
ICD-10 Finland
Optic neuritis
6.1
10.3
27
45
M46.8
ICD-10 Finland
Other specified inflammatory spondylopathies
23.5
10.2
14
6
NGF15
NOMESCO Finland
Total synovectomy of knee, arthroscopic
4.9
10.2
32
66
TAB00
NOMESCO Finland
Lumbar puncture
2.6
10.1
75
301
H35.0
ICD-10 Finland
Background retinopathy and retinal vascular changes
9.2
10.0
20
22
S01KA02
ATC
hypromellose; ophthalmic
3.7
10.0
42
115
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
1.6
10.0
262
1714
H40.11
ICD-10 Finland
Low pressure glaucoma
3.8
9.9
40
106
NG1AE
NOMESCO Finland
Knee joint ultrasound exmination
4.4
9.8
34
78
K50.8
ICD-10 Finland
Other Crohn disease
4.0
9.8
38
97
K51.5
ICD-10 Finland
Left sided colitis
3.1
9.8
53
177
ND2DA
NOMESCO Finland
Bilateral hand X-ray examination
3.6
9.7
42
118
Z01.5
ICD-10 Finland
Diagnostic skin and sensitization tests
1.9
9.7
146
806
NF2AT
NOMESCO Finland
Injection to hip joint with ultrasound guidance
7.9
9.6
21
27
H02AB04
ATC
methylprednisolone; systemic
1.6
9.6
232
1482
CKC20
NOMESCO Finland
Cryopexy of undetached retina
11.4
9.6
17
15
H35.9
ICD-10 Finland
Retinal disorder, unspecified
8.4
9.6
20
24
NH1AE
NOMESCO Finland
Ankle joint ultrasound examination
6.0
9.5
25
42
F29
ICPC
Eye symptom/complaint other
1.9
9.5
131
701
SPAT1256
SPAT
Intramuscular and subcutaneous injection
1.4
9.4
645
5157
CGG60
NOMESCO Finland
Reinforcement of sclera using graft
100.5
9.4
10
*
CJF45
NOMESCO Finland
Removal and implantation of artificial lens in anterior chamber with iridectomy or iridotomy
100.5
9.4
10
*
CKC65
NOMESCO Finland
Removal of buckling implant from sclera
100.5
9.4
10
*
H33.4
ICD-10 Finland
Traction detachment of retina
17.6
9.4
14
8
CGG31
NOMESCO Finland
Posterior corneal lamellar transplantation
+∞
9.4
9
*
3719
FHL
Other measure in this category
+∞
9.4
9
*
H21.9
ICD-10 Finland
Disorder of iris and ciliary body, unspecified
+∞
9.4
9
*
CGG99
NOMESCO Finland
Other reconstructive operations on cornea and sclera
+∞
9.4
9
*
J01MA02
ATC
ciprofloxacin; systemic
1.4
9.3
571
4477
CA1AE
NOMESCO Finland
Eye and orbita ultrasound examination
10.7
9.3
17
16
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
1.9
9.2
127
679
SPAT1301
SPAT
No procedures
1.4
9.1
485
3701
J01MA12
ATC
levofloxacin; systemic
1.6
9.1
265
1776
H27.1
ICD-10 Finland
Dislocation of lens
11.5
9.1
16
14
Z03.89
ICD-10 Finland
Observation for other suspected diseases and conditions
1.7
9.0
197
1221
N02AA59
ATC
codeine, combinations excl. psycholeptics; systemic
1.4
9.0
700
5708
7143X
ICD-9 Finland
Rheumatoid arthritis and other inflammatory polyarthropathies, Juvenile chronic polyarthritis[POLYARTHRITIS JUVENILIS NUD]
36.9
9.0
11
*
XQ800
NOMESCO Finland
Prick test
2.0
9.0
121
640
E10.7
ICD-10 Finland
Type 1 diabetes mellitus, With multiple complications
3.3
9.0
44
137
CK2L4
NOMESCO Finland
Wide-field/panoramic imaging of ocular fundus
6.5
9.0
22
34
D86
ICD-10 Finland
Sarcoidosis
18.7
8.9
13
7
TGC00
NOMESCO Finland
Bronchial lavation
3.1
8.9
46
149
H02AB09
ATC
hydrocortisone; systemic
3.1
8.9
46
149
M02.3
ICD-10 Finland
Reiter disease
24.1
8.9
12
5
DM1QA
NOMESCO Finland
Paranasal sinuses X-ray examination in one projection
2.3
8.9
79
349
Z04.8
ICD-10 Finland
Examination and observation for other specified reasons
1.7
8.9
186
1141
J01DA09
ATC
[U] cefadroxil; inhalant, oral
1.4
8.8
419
3127
M05BA01
ATC
etidronic acid; systemic
7.2
8.7
20
28
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
1.9
8.7
121
650
CA1BG
NOMESCO Finland
Eye and orbita MRI examination with high intensity magnet
14.1
8.7
14
10
D07AC01
ATC
betamethasone; topical
1.4
8.6
500
3870
A02BC05
ATC
esomeprazole; systemic
1.4
8.6
615
4938
H35.31
ICD-10 Finland
Senile macular degeneration (atrophic)(exudative)
2.5
8.6
63
254
R51.80
ICD-10 Finland
Headache
1.6
8.6
234
1543
H26.1
ICD-10 Finland
Traumatic cataract
11.6
8.6
15
13
B00.5
ICD-10 Finland
Herpesviral ocular disease
16.4
8.5
13
8
E0000UV
ATC
NA
1.4
8.5
613
4922
TCG40
NOMESCO Finland
Measurement of higher-grade errors of refraction
9.0
8.5
17
19
K51.1
ICD-10 Finland
Ulcerative (chronic) ileocolitis
5.0
8.5
26
53
37872
ICD-8 Finland
Other diseases of eye, Aphakia artefacta, acquisita
27.6
8.5
11
*
H54.0
ICD-10 Finland
Blindness, binocular
27.6
8.5
11
*
TEG10
NOMESCO Finland
Injection of diagnostic or therapeutic substance into mandibular joint
20.1
8.5
12
6
9269
FHL
Other measure in this category
20.1
8.5
12
6
M08.8
ICD-10 Finland
Other juvenile arthritis
20.1
8.5
12
6
H3603, E109
ICD-10 Finland
NA
90.5
8.4
9
*
M54.9
ICD-10 Finland
Dorsalgia, unspecified
1.7
8.4
173
1056
L04AA24
ATC
abatacept; parenteral
7.9
8.4
18
23
36609
ICD-8 Finland
Other inflammation of uveal tract, Unspecified
+∞
8.3
8
*
M35.2
ICD-10 Finland
Behçet disease
+∞
8.3
8
*
4AA17
NOMESCO Finland
NA
+∞
8.3
8
*
3711
FHL
Cyclodiateria or cryocoagulation
+∞
8.3
8
*
H02.4
ICD-10 Finland
Ptosis of eyelid
2.8
8.3
50
180
L04AC10
ATC
secukinumab; parenteral
9.5
8.3
16
17
NDG30
NOMESCO Finland
Fusion of wrist, total
7.1
8.2
19
27
SHB00
NOMESCO Finland
Prepation and fitting of bite rail to mouth
1.7
8.2
153
908
NHG20
NOMESCO Finland
Fusion of talocrural joint
7.6
8.2
18
24
M01AB01
ATC
indometacin; systemic, rectal
1.9
8.1
110
584
H19.3*M35.0
ICD-10 Finland
Keratoconjunctivitis sicca
33.5
8.1
10
*
R05
ICD-10 Finland
Cough
1.5
8.1
288
2024
R42
ICD-10 Finland
Dizziness and giddiness
1.5
8.0
312
2231
XCW10
NOMESCO Finland
Assessment of vision
6.3
8.0
20
32
H10.9
ICD-10 Finland
Conjunctivitis, unspecified
2.1
8.0
86
419
M01AE02
ATC
naproxen; oral, rectal
1.3
7.9
903
7765
H53.1
ICD-10 Finland
Subjective visual disturbances
2.0
7.9
99
513
NA2BG
NOMESCO Finland
Thoracal spine MRI examination with high intensity magnet
3.0
7.9
43
146
H3601, E103
ICD-10 Finland
NA
5.2
7.9
23
45
F02
ICPC
Red eye
2.3
7.8
72
325
UGC12
NOMESCO Finland
Flexible bronchoscopy
1.9
7.8
112
611
DM1AA
NOMESCO Finland
Paranasal sinuses X-ray examination without contrast
2.5
7.8
60
247
XG410
NOMESCO Finland
Flow-volume spirometry
2.3
7.8
67
295
R1220
NOMESCO Finland
Psychological examination of need and possibilities to rehabilitation
4.5
7.8
26
59
H17.8
ICD-10 Finland
Other corneal scars and opacities
45.2
7.7
9
*
G35
ICD-10 Finland
Multiple sclerosis
3.6
7.7
33
94
S18
ICPC
Laceration/cut
1.4
7.7
601
4876
S10
ICPC
Boil/carbuncle
2.1
7.7
83
403
SAA03
NOMESCO Finland
Extended examination of mouth
1.3
7.6
605
4919
M01AH05
ATC
etoricoxib; oral
1.3
7.6
900
7763
N03AX12
ATC
gabapentin; oral
1.6
7.5
226
1525
XQ802
NOMESCO Finland
Epicutan test
2.3
7.5
65
286
WZC10
NOMESCO Finland
Extensive specialist consultion with written report
2.2
7.5
76
361
H02AB08
ATC
triamcinolone; systemic
5.8
7.5
20
35
R01AD08
ATC
fluticasone; nasal
1.4
7.5
425
3262
L28
ICPC
Limited function/disability (L)
1.6
7.5
215
1434
K50.9
ICD-10 Finland
Crohn disease, unspecified
3.6
7.5
32
91
NA3BG
NOMESCO Finland
Lumbar spine MRI examination with high intensity magnet
1.7
7.5
138
817
SPAT1310
SPAT
Counselling related to known health issue
1.4
7.4
478
3752
H16.8
ICD-10 Finland
Other keratitis
80.4
7.4
8
*
CHC10
NOMESCO Finland
Peripheral iridectomy
80.4
7.4
8
*
3665A
ICD-9 Finland
Cataract, After-cataract
80.4
7.4
8
*
R2120
NOMESCO Finland
Counselling and guidance concerning rehabilitation services and social security
5.0
7.4
22
44
K50.0
ICD-10 Finland
Crohn disease of small intestine
3.4
7.4
33
97
M05BA07
ATC
risedronic acid; oral
2.6
7.4
51
199
CHB65
NOMESCO Finland
Posterior synechiolysis
+∞
7.3
7
*
1BA01
NOMESCO Finland
NA
+∞
7.3
7
*
F73
ICPC
Eye infection/inflammation other
3.2
7.3
36
115
CKC60
NOMESCO Finland
Local buckling of sclera using implant
6.3
7.2
18
29
C10AC01
ATC
colestyramine; oral
2.8
7.2
46
170
J02AC01
ATC
fluconazole; systemic
1.3
7.2
610
4996
71239
ICD-8 Finland
Rheumatoid arthritis and allied conditions, Arthritis rheumatoides NUD
5.5
7.2
20
37
F99
ICPC
Eye/adnexa disease other
5.8
7.2
19
33
SFA20
NOMESCO Finland
Filling on two surfaces of tooth
1.3
7.2
883
7635
CD2S4
NOMESCO Finland
Photography of eye
7.3
7.2
16
22
H43.3
ICD-10 Finland
Other vitreous opacities
4.0
7.2
27
69
A10AA01
ATC
NA
2.8
7.2
44
162
SAA02
NOMESCO Finland
Basic examination of mouth
1.3
7.2
1029
9093
J01AA02
ATC
doxycycline; systemic
1.3
7.2
1238
11238
CHC03
NOMESCO Finland
Laser iridoplasty
30.1
7.1
9
*
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
1.6
7.1
167
1058
R50.9
ICD-10 Finland
Fever, unspecified
1.6
7.1
205
1372
SPAT1253
SPAT
Initiation, adjustment, discontinuation or repetition of medication
1.4
7.1
461
3620
QDB10
NOMESCO Finland
Major dressing of wound of skin of lower limb
2.2
7.1
72
342
NHG24
NOMESCO Finland
Fusion of subtalar joint and between bones of ankle
5.6
7.1
19
34
3660C
ICD-9 Finland
Cataract, Infantile, juvenile and presenile cataract[CATARACTA PRAESENILIS]
8.8
7.0
14
16
M01AX17
ATC
nimesulide; oral
1.4
7.0
347
2597
ZX140
NOMESCO Finland
Intra articular
4.5
7.0
23
52
SPAT1223
SPAT
Implementation of physical therapy rehabilitation plan
1.4
6.9
406
3133
H57.0
ICD-10 Finland
Anomalies of pupillary function
6.3
6.9
17
27
R2130
NOMESCO Finland
Counselling and guidance which enhance independent living
1.7
6.9
126
745
GD1ED
NOMESCO Finland
Extensive high resolution CT examination of lungs
2.7
6.9
45
172
M79.6
ICD-10 Finland
Pain in limb
1.3
6.9
514
4126
M01AC06
ATC
meloxicam; systemic, rectal
1.3
6.8
538
4351
H40.19
ICD-10 Finland
Other primary glaucoma with open ventricular angle
9.3
6.8
13
14
NA1BA
NOMESCO Finland
Cervical spine extensive X-ray examination without contrast
4.5
6.8
22
49
326
Kela drug reimbursment
Adalimumab, golimumab, infliximab and ustekinumab (intestinal diseases)
5.3
6.8
19
36
CHB99
NOMESCO Finland
Other operation on anterior chamber and anterior chamber angle
40.2
6.8
8
*
37404
ICD-8 Finland
Cataract, Secundaria
40.2
6.8
8
*
3747
FHL
Combined ablation and vitreous surgery with coagulation
40.2
6.8
8
*
H18.6
ICD-10 Finland
Keratoconus
40.2
6.8
8
*
WX110
NOMESCO Finland
Local anesthesy
1.3
6.8
1094
9792
RT160
NOMESCO Finland
NA
16.7
6.7
10
6
H40.12
ICD-10 Finland
Pigmentary glaucoma
16.7
6.7
10
6
R3120
NOMESCO Finland
Training in mobility skills
16.7
6.7
10
6
CJ2M4
NOMESCO Finland
Scans and measurement printouts for intraocular lens power calculation
4.7
6.7
21
45
SPAT1325
SPAT
Vaccination
1.3
6.7
507
4073
D07XC01
ATC
betamethasone, combinations; topical
1.6
6.7
171
1109
A10AB01
ATC
insulin (human); parenteral (insulins and analog. for injection, fast-acting)
2.3
6.7
57
251
H10.0
ICD-10 Finland
Mucopurulent conjunctivitis
1.9
6.6
89
475
M06
ICD-10 Finland
Other rheumatoid arthritis
5.2
6.6
19
37
CA1ME
NOMESCO Finland
Ultrasound oculometry
5.2
6.6
19
37
-44
ICPC
Preventive immunization/medic
1.7
6.6
125
744
H04.5
ICD-10 Finland
Stenosis and insufficiency of lacrimal passages
2.8
6.6
39
140
NA6CG
NOMESCO Finland
Sacro-iliac joint extensive MRI examination with high intensity magnet
7.8
6.6
14
18
EG1AA
NOMESCO Finland
Mandibular joint X-ray examination
7.8
6.6
14
18
A07EA06
ATC
budesonide; oral, local oral
2.3
6.6
57
254
XG470
NOMESCO Finland
Measurement of diffusion capastity of the lungs
2.5
6.6
47
189
9311
FHL
Knee cleansing surgery (synovectomy, debridement)
12.3
6.6
11
9
D50.9
ICD-10 Finland
Iron deficiency anaemia, unspecified
1.8
6.5
105
594
ZX199
NOMESCO Finland
Other rote
10.1
6.5
12
12
H10.1
ICD-10 Finland
Acute atopic conjunctivitis
2.6
6.5
44
172
XG412
NOMESCO Finland
Flow-volume spirometry with bronchospasmolysis
1.9
6.5
88
471
R06.0
ICD-10 Finland
Dyspnoea
1.4
6.5
346
2625
H36.09*E10.3
ICD-10 Finland
Insulin-dependent diabetes mellitus - Diabetic retinopathy
4.5
6.5
21
47
O99.89
ICD-10 Finland
Other specified diseases and conditions complicating pregnancy, childbirth and the puerperium
3.1
6.4
33
109
SPAT1312
SPAT
General health counselling
1.3
6.4
477
3819
M01AE03
ATC
ketoprofen; systemic, rectal
1.3
6.4
538
4385
M06.8
ICD-10 Finland
Other specified rheumatoid arthritis
4.7
6.4
20
43
CHF15
NOMESCO Finland
Cryotherapy of ciliary body
14.4
6.4
10
7
S05.0
ICD-10 Finland
Injury of conjunctiva and corneal abrasion without mention of foreign body
3.1
6.4
32
104
109
Kela drug reimbursment
Multiple sclerosis
3.8
6.4
25
67
K02.1
ICD-10 Finland
Caries of dentine
1.3
6.4
886
7742
L04AC07
ATC
tocilizumab; parenteral
8.2
6.3
13
16
1350A
ICD-9 Finland
Sarcoidosis[SARCOIDOSIS]
8.2
6.3
13
16
H35.5
ICD-10 Finland
Hereditary retinal dystrophy
8.2
6.3
13
16
C03CA01
ATC
furosemide; systemic
1.4
6.3
355
2717
H04.3
ICD-10 Finland
Acute and unspecified inflammation of lacrimal passages
6.0
6.3
16
27
D01AC20
ATC
imidazoles/triazoles in combination with corticosteroids; topical
1.4
6.3
322
2420
EG1CG
NOMESCO Finland
Extensive MRI examination of mandipular joint with high intensity magnet
11.1
6.3
11
10
SDA02
NOMESCO Finland
Parodonthologic therapy
1.3
6.3
483
3883
TCC40
NOMESCO Finland
Closure of lacrimal canaliculus with plug
9.3
6.3
12
13
LCA06
NOMESCO Finland
Biopsy of endometrium
1.6
6.3
159
1030
D07AB02
ATC
hydrocortisone butyrate; topical
1.4
6.3
401
3133
H16.1
ICD-10 Finland
Other superficial keratitis without conjunctivitis
18.1
6.3
9
5
CHB60
NOMESCO Finland
Anterior synechiolysis
+∞
6.3
6
*
3649
FHL
Other measure in this category
+∞
6.3
6
*
H16.3
ICD-10 Finland
Interstitial and deep keratitis
+∞
6.3
6
*
CKD99
NOMESCO Finland
Other intraoclular operations on vitreous body and retina
+∞
6.3
6
*
H21.5
ICD-10 Finland
Other adhesions and disruptions of iris and ciliary body
+∞
6.3
6
*
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
1.5
6.2
197
1346
SPAT1262
SPAT
Handing over of treatment supplies
1.5
6.2
245
1756
CS2P4
NOMESCO Finland
Optic nerve head imaging
6.3
6.2
15
24
56310
ICD-8 Finland
Chronic enteritis and ulcerative colitis, Ulcerative colitis
7.7
6.1
13
17
M01CB03
ATC
auranofin; oral
4.2
6.1
21
50
SFA10
NOMESCO Finland
Fillning on one surface of tooth
1.3
6.1
816
7076
M31.3
ICD-10 Finland
Wegener granulomatosis
8.6
6.1
12
14
3793C
ICD-9 Finland
Other disorders of eye, Aphakia and other disorders of lens[PSEUDOPHAKIA]
8.6
6.1
12
14
7140B
ICD-9 Finland
Rheumatoid arthritis and other inflammatory polyarthropathies, Rheumatoid arthritis[ARTHRITIS RHEUMATOIDES SERONEGATIVA]
4.9
6.0
18
37
J01DA01
ATC
[U] cefalexin; systemic
1.3
6.0
968
8593
EP1AE
NOMESCO Finland
Neck ultrasound examination
1.9
6.0
84
457

LabWAS

↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
393
633
7.53
242.50
2.9
2.0
u/l
38.3
39.3
0.38
364
559
(3008898) HLA-B27 [Presence]
308
547
6.50
170.56
1.1
1.1
—
—
—
0
0
(3012110) Lysozyme [Mass/volume] in Serum or Plasma
261
391
7.56
169.87
3.0
2.1
mg/l
10.3
11.6
1.44
248
356
(44786774) Adalimumab [Mass/volume] in Serum or Plasma
106
39
28.69
157.02
2.0
3.1
mg/l
9.9
11.1
0.54
76
29
(3006315) Basophils [#/volume] in Blood
1361
7798
3.50
141.54
11.9
5.8
e9/l
0.0
0.0
1.53
1282
6762
(3001604) Monocytes [#/volume] in Blood
1350
7770
3.42
137.75
11.9
5.8
e9/l
0.6
0.6
2.48
1270
6736
(42870588) Differential panel, method unspecified - Blood
1048
5210
3.20
137.57
11.2
5.8
—
—
—
0
0
(3013115) Eosinophils [#/volume] in Blood
1381
8069
3.47
137.16
12.2
6.0
e9/l
0.2
0.2
0.09
1301
7099
(3019198) Lymphocytes [#/volume] in Blood
1371
8013
3.42
135.29
12.0
5.8
e9/l
1.9
2.0
0.63
1289
7081
(3022096) Basophils/100 leukocytes in Blood
1272
7115
3.29
135.24
12.3
5.9
%
0.8
0.7
7.97
1223
6645
(3006504) Eosinophils/100 leukocytes in Blood
1294
7334
3.30
134.01
12.2
5.9
%
2.8
2.8
0.30
1244
6843
(3019069) Monocytes/100 leukocytes in Blood
1294
7378
3.26
131.72
12.5
6.2
%
8.9
8.5
3.96
1242
6916
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
251
467
6.02
131.41
1.7
1.6
iu/ml
0.7
13.8
0.47
65
88
(3002030) Lymphocytes/100 leukocytes in Blood
1305
7608
3.19
125.13
12.4
6.0
%
28.2
28.3
0.06
1248
7106
(3018010) Neutrophils/100 leukocytes in Blood
1292
7496
3.17
124.82
11.9
5.7
%
57.1
57.0
0.05
1238
7030
(3013650) Neutrophils [#/volume] in Blood by Automated count
1426
9040
3.18
112.17
14.4
8.9
e9/l
4.0
4.1
0.64
1339
7905
(3037522) Nuclear Ab [Titer] in Serum
526
2097
3.07
95.52
1.5
1.3
titre
549.6
523.0
0.11
138
438
(3013707) Erythrocyte sedimentation rate by Westergren method
1573
11465
2.97
79.05
8.3
4.0
mm/h
12.3
11.8
0.82
1508
10612
(3002179) Metamyelocytes/100 leukocytes in Blood
330
1182
3.16
70.33
4.6
4.0
%
0.4
0.6
1.00
71
270
(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay
60
42
14.71
66.64
2.7
3.5
au/ml
103.8
32.0
—
8
9
(3021440) Promyelocytes/100 leukocytes in Blood
330
1230
3.03
65.34
5.3
4.3
%
0.1
0.1
0.16
83
336
(3017181) Myelocytes/100 leukocytes in Blood
338
1293
2.95
63.79
5.2
4.2
%
0.8
1.0
0.45
86
365
(3025159) Blasts/100 leukocytes in Blood
312
1167
2.99
61.15
5.2
4.3
%
0.0
0.4
0.64
74
287
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
1549
11900
2.50
57.41
10.8
7.3
u/l
76.5
78.2
0.98
1496
11200
(3037467) Urinalysis macro (dipstick) panel - Urine
1436
10776
2.28
54.53
6.6
4.2
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
624
3510
2.15
49.63
7.8
4.4
—
—
—
0
0
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
272
1064
2.81
48.50
2.5
2.4
au/ml
31.7
23.1
—
8
68
(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma
60
69
8.94
48.03
2.6
3.0
u/ml
493.8
1466.0
1.75
60
69
(3009445) Proteinase 3 Ab [Units/volume] in Serum
189
604
3.36
47.90
1.9
1.4
u/ml
11.0
10.5
—
6
16
(3021589) Normoblasts [#/volume] in Blood
1021
6959
1.99
47.04
16.4
9.2
e9/l
0.0
0.0
0.44
928
5720
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
250
965
2.83
45.59
1.4
1.3
au/ml
55.2
51.6
—
9
45
(3035350) Ketones [Presence] in Urine by Test strip
1070
7628
1.90
40.86
4.7
3.5
estimate
0.0
0.0
0.00
256
1438
(3009261) Glucose [Presence] in Urine by Test strip
1080
7726
1.90
40.76
4.7
3.5
estimate
0.0
0.0
0.18
256
1423
(3014148) Varicella zoster virus Ab [Titer] in Serum
90
188
4.97
40.73
1.1
1.2
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
1068
7657
1.88
39.56
6.4
4.8
estimate
0.0
0.0
0.38
264
1474
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
488
2712
2.07
38.55
1.3
1.3
iu/ml
28.8
32.6
0.21
147
863
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
94
214
4.57
38.35
1.1
1.1
—
—
—
0
0
(3030905) Polymorphonuclear cells [#/volume] in Blood
115
306
3.93
38.21
4.5
3.2
e9/l
4.3
4.2
0.10
115
306
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
117
318
3.85
37.73
4.6
3.5
%
58.1
57.9
0.06
117
318
(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence
147
476
3.26
36.29
1.6
1.6
titre
320.0
144.7
—
5
17
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
58
102
5.83
31.70
1.2
1.2
—
—
—
0
0
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
904
6436
1.76
31.62
2.9
2.3
nmol/l
75.9
76.6
0.31
849
5825
(3028679) Herpes simplex virus Ab [Presence] in Serum
49
73
6.86
31.49
1.2
1.2
—
—
—
0
0
(40758558) Short blood count panel - Blood
610
3954
1.79
28.88
10.4
6.5
—
—
—
0
0
(3011412) CD3 cells [#/volume] in Blood
62
129
4.93
28.19
2.1
2.3
e9/l
1.1
1.2
0.47
36
84
(3021879) Hepatitis B virus core Ab [Presence] in Serum
249
1202
2.23
27.55
1.3
1.4
—
—
—
0
0
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
999
7526
1.67
26.78
7.4
6.5
mmol/l
1.2
1.2
3.51
834
6365
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
63
141
4.58
26.26
1.2
1.2
—
—
—
0
0
(3005719) IgG [Mass/volume] in Serum or Plasma
243
1191
2.19
25.83
3.5
2.7
g/l
10.8
10.6
0.29
228
1079
(3017143) Hepatitis C virus Ab [Presence] in Serum
338
1880
1.97
25.53
1.5
1.6
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
129
475
2.84
25.37
1.9
1.8
—
—
—
0
0
(3015171) Extractable nuclear Ab [Units/volume] in Serum
148
586
2.65
25.31
1.2
1.2
u/ml
0.7
0.8
0.09
13
43
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
41
64
6.52
25.22
1.2
1.2
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
423
2564
1.83
24.42
1.3
1.3
u/ml
15.8
12.2
0.31
138
1019
(3048689) Calprotectin [Mass/mass] in Stool
340
1947
1.90
23.39
3.3
2.4
ug/g
150.1
109.3
0.93
288
1535
(3024561) Albumin [Mass/volume] in Serum or Plasma
871
6493
1.62
23.13
5.2
4.8
g/l
35.4
35.7
0.99
816
6044
(3018095) Leukocytes [#/volume] in Urine
749
5398
1.63
22.70
4.5
3.6
e6/l
79.3
97.2
0.34
532
3764
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
1763
15883
2.21
22.66
21.4
13.3
mg/l
18.5
23.1
10.19
1535
12450
(3031040) Bacteria [#/volume] in Urine by Automated count
1247
10245
1.61
21.26
5.4
4.3
e6/l
10.7
2154.8
2.34
11
139
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
564
3837
1.66
21.17
2.6
2.2
mg/l
3.1
3.0
0.50
500
3239
(3041096) Erythrocytes [Presence] in Urine by Automated
613
4261
1.64
21.14
4.2
3.2
—
—
—
0
0
(3018418) pH of Serum or Plasma
625
4393
1.62
20.47
4.5
3.9
ph
7.4
7.4
0.34
139
830
(3017766) Complement C4 [Mass/volume] in Serum or Plasma
116
456
2.64
20.11
2.1
1.6
g/l
0.2
0.2
0.83
110
430
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
792
5908
1.58
20.09
5.0
3.7
—
—
—
0
0
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
890
6822
1.56
20.01
6.1
5.9
mmol/l
1.2
1.2
3.56
820
6171
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
39
74
5.36
19.70
1.0
1.1
miu/ml
1627.4
1578.9
0.09
39
74
(3021788) Differential panel - Synovial fluid
82
271
3.12
19.54
2.0
1.5
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
402
2547
1.73
19.47
1.5
1.6
—
—
—
0
0
(3028026) IgM [Mass/volume] in Serum or Plasma
188
929
2.13
19.41
2.1
1.8
g/l
1.3
1.5
0.36
178
854
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
103
391
2.73
19.12
1.7
1.4
—
—
—
0
0
(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay
21
21
10.10
18.50
1.1
1.1
—
—
—
0
0
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
998
7945
1.53
18.27
6.1
6.2
umol/l
11.0
11.4
0.31
945
7545
(3000620) Complement C3 [Mass/volume] in Serum or Plasma
115
473
2.52
18.18
2.1
1.6
g/l
1.2
1.2
0.23
110
446
(3011397) Hemoglobin [Presence] in Urine by Test strip
511
3504
1.62
18.12
4.4
3.5
—
—
—
0
0
(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood
41
88
4.74
18.01
2.4
2.3
e9/l
0.2
0.2
0.37
36
79
(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood
42
92
4.64
18.01
2.4
2.2
e6/l
473.0
538.5
0.33
36
80
(3000850) Epithelial cells [#/volume] in Urine
470
3170
1.64
17.76
3.0
2.5
e6/l
4.9
6.3
1.36
417
2776
(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood
44
104
4.31
17.18
2.0
2.3
%
11.8
12.5
0.11
18
51
(3007853) Bacteria identified in Skin by Aerobe culture
295
1781
1.77
16.72
2.2
1.6
—
—
—
0
0
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
42
98
4.36
16.67
2.1
2.3
—
—
—
0
0
(3000475) Leukocytes [#/volume] in Synovial fluid
93
360
2.66
16.64
2.1
1.7
e6/l
10096.9
13401.7
0.43
71
258
(3029937) Albumin [Presence] in Urine by Test strip
567
4052
1.56
16.63
5.2
3.9
estimate
0.0
0.0
1.28
258
1424
(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma
24
33
7.35
16.54
1.2
1.1
—
—
—
0
0
(44817194) Complement alternate pathway AH50 actual/normal in Serum by Immunoassay
24
33
7.35
16.54
1.2
1.1
%
91.1
97.2
0.40
24
33
(3003329) Lymphocytes/100 leukocytes in Synovial fluid
48
125
3.91
16.49
1.9
1.5
%
40.4
31.0
0.82
30
74
(3019309) Folate [Moles/volume] in Red Blood Cells
405
2677
1.65
16.43
1.8
1.7
nmol/l
1181.6
1168.9
0.10
311
2011
(3028192) IgG subclass 2 [Mass/volume] in Serum
53
149
3.63
16.33
1.5
1.3
g/l
3.1
2.9
0.29
38
107
(3027135) IgG subclass 1 [Mass/volume] in Serum
53
149
3.63
16.33
1.5
1.3
g/l
6.1
6.9
0.85
39
107
(3024139) IgG subclass 3 [Mass/volume] in Serum
53
149
3.63
16.33
1.5
1.3
g/l
0.3
0.4
0.96
37
105
(3024980) IgG subclass 4 [Mass/volume] in Serum
72
246
3.00
16.24
1.6
1.7
g/l
0.6
0.8
0.65
54
188
(3002582) Erythrocytes [#/volume] in Urine
621
4551
1.54
16.18
3.9
3.2
e6/l
87.9
75.9
0.08
498
3477
(4062490)
53
152
3.56
15.86
1.5
1.4
—
—
—
0
0
(3032080) INR in Blood by Coagulation assay
770
5942
1.49
15.51
10.1
8.9
inr
1.2
1.2
1.16
254
1740
(3017732) Neutrophils [#/volume] in Blood
198
1080
1.93
15.48
3.1
2.9
e9/l
4.2
4.1
0.15
148
856
(3007164) IgA [Mass/volume] in Serum or Plasma
456
3151
1.58
15.28
1.7
1.4
g/l
2.5
2.4
0.66
302
1927
(3026008) Bacteria identified in Urine by Culture
618
4582
1.51
15.01
3.6
3.0
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
67
231
2.97
14.90
1.6
1.4
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
56
174
3.28
14.82
1.1
1.3
—
—
—
0
0
(3030467) Casts [#/volume] in Urine by Automated count
568
4166
1.51
14.41
3.8
3.0
e6/l
0.2
0.4
6.88
458
3134
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
57
183
3.18
14.32
2.1
2.6
—
—
—
0
0
(3026782) Osmolality of Urine
432
2988
1.57
14.30
3.6
2.7
mosm/kgh2o
534.2
549.0
0.68
371
2545
(3042936) Bacteria identified in Isolate by Culture
328
2129
1.65
14.10
2.5
2.0
—
—
—
0
0
(21494815) CD4 cells/100 lymphocytes in Specimen
45
126
3.63
13.98
1.5
2.2
%
56.9
38.3
—
8
12
(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid
55
177
3.17
13.77
1.9
1.6
%
42.3
60.1
2.19
31
111
(36304419) Bacteria [Presence] in Urine
555
4088
1.50
13.67
3.6
3.0
—
—
—
0
0
(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative
18
22
8.25
13.64
1.0
1.0
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
43
119
3.67
13.59
1.4
1.2
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
43
119
3.67
13.59
1.4
1.2
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
43
119
3.67
13.59
1.4
1.2
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
43
120
3.64
13.43
1.4
1.2
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
43
120
3.64
13.43
1.4
1.2
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
43
120
3.64
13.43
1.4
1.2
—
—
—
0
0
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
626
4750
1.47
13.20
3.1
2.5
u/l
61.5
56.8
0.61
573
4393
(3022948) Iron [Moles/volume] in Serum or Plasma
351
2363
1.59
12.92
2.5
2.4
umol/l
12.3
13.4
2.03
325
2187
(3034891) Synovial lining cells/100 cells in Synovial fluid
30
66
4.60
12.84
1.9
1.3
%
4.4
6.3
—
9
10
(3002385) Erythrocyte distribution width [Ratio]
1496
13387
1.51
12.82
24.7
16.2
%
13.8
13.6
2.55
1477
13101
(46235355) HIV 1 and 2 tests - Meaningful Use set
438
3106
1.53
12.80
1.7
1.9
—
—
—
0
0
(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection
17
21
8.16
12.76
1.2
2.7
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
186
1060
1.83
12.65
1.6
1.6
—
—
—
0
0
(3009871) Measles virus Ab [Titer] in Serum
24
44
5.51
12.60
1.8
1.6
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
719
5640
1.44
12.57
3.8
3.4
ng/l
58.7
47.3
0.29
483
3706
(3004789) Transferrin [Mass/volume] in Serum or Plasma
327
2179
1.60
12.54
2.5
2.4
g/l
2.4
2.3
0.35
298
2022
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
22
38
5.84
12.27
2.2
2.2
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
763
6082
1.42
12.07
2.1
2.0
pmol/l
91.8
96.2
1.68
393
3189
(3019832) Treponema pallidum Ab [Presence] in Serum
262
1675
1.65
11.84
1.4
1.7
—
—
—
0
0
(3036481) Cortisol [Moles/volume] in Serum or Plasma
238
1484
1.69
11.83
2.3
2.1
nmol/l
345.6
375.3
1.86
219
1368
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
1794
16849
1.86
11.82
18.6
9.9
u/l
25.9
26.2
0.30
1749
16296
(21494814) CD8 cells/100 lymphocytes in Specimen
25
52
4.86
11.44
1.5
2.3
—
—
—
0
0
(3016228) CD19 cells/100 cells in Blood
25
52
4.86
11.44
1.6
2.3
%
5.8
6.5
0.18
25
52
(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection
16
21
7.67
11.43
1.5
3.3
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
277
1814
1.61
11.35
1.5
1.4
—
—
—
0
0
(3001122) Ferritin [Mass/volume] in Serum or Plasma
857
7034
1.39
11.17
3.4
2.8
ug/l
123.7
117.2
0.18
800
6515
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
661
5193
1.41
11.13
4.2
3.2
u/l
31.5
32.4
0.30
625
4941
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
75
323
2.38
10.81
1.4
1.5
—
—
—
0
0
(3013826) Glucose [Moles/volume] in Serum or Plasma
1056
9007
1.38
10.71
4.9
4.7
mmol/l
6.6
6.7
0.54
996
8395
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
437
3202
1.47
10.65
1.8
1.7
pmol/l
35040891.4
30237361.5
0.07
371
2659
(40768443) Skin Pathology biopsy report
121
634
1.97
10.64
1.2
1.2
—
—
—
0
0
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
298
2020
1.56
10.50
2.6
2.5
%
20.8
23.3
2.36
249
1730
(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen
21
41
5.17
10.32
1.5
2.3
—
—
—
0
0
(3020630) Protein [Mass/volume] in Serum or Plasma
190
1157
1.71
10.28
2.2
2.8
g/l
68.8
66.5
3.52
167
1058
(3023368) Bacteria identified in Blood by Culture
520
3961
1.43
10.26
5.3
4.2
—
—
—
0
0
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
197
1215
1.69
10.17
4.1
3.7
mmol/l
1.2
1.2
0.01
177
1041
(3004588) Protein electrophoresis panel - Serum or Plasma
162
954
1.76
9.87
2.0
2.5
—
—
—
0
0
(3026493) Urate [Moles/volume] in Serum or Plasma
511
3910
1.42
9.75
2.7
2.6
umol/l
4842.4
5778.9
0.15
435
3402
(3007566) Smooth muscle Ab [Titer] in Serum
88
427
2.11
9.56
1.3
1.2
titre
132.9
96.9
—
7
32
(3044941) Cell count panel - Synovial fluid
61
254
2.45
9.50
1.6
1.4
—
—
—
0
0
(3034770) Mitochondria Ab [Titer] in Serum
89
435
2.10
9.49
1.4
1.3
titre
1218.0
1029.2
—
5
13
(3023103) Potassium [Moles/volume] in Serum or Plasma
1722
16158
1.58
9.26
18.6
15.2
mmol/l
3.9
4.0
3.22
1687
15712
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
93
468
2.04
9.18
2.4
3.0
—
—
—
0
0
(3022145) Colonoscopy Study observation
252
1694
1.56
9.17
1.5
1.3
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
85
415
2.10
9.10
2.2
1.7
—
—
—
0
0
(3019550) Sodium [Moles/volume] in Serum or Plasma
1717
16114
1.57
9.07
18.5
15.1
mmol/l
139.5
139.6
1.12
1685
15692
(40761536) Microorganisms panel - Urine sediment
209
1351
1.61
8.97
5.2
3.8
—
—
—
0
0
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
66
293
2.30
8.93
1.5
1.5
u/ml
109.1
127.3
0.46
23
46
(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood
34
107
3.22
8.92
2.1
2.1
e6/l
1064.0
665.8
0.90
21
37
(3003458) Phosphate [Moles/volume] in Serum or Plasma
286
1989
1.51
8.90
5.9
5.8
mmol/l
1.0
1.0
0.06
267
1842
(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum
70
320
2.23
8.85
1.3
1.2
u/ml
32.4
44.9
—
9
33
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
181
1133
1.66
8.83
4.2
3.9
ng/l
71.8
87.3
1.88
160
989
(3027945) Reticulocytes/100 erythrocytes in Blood
240
1622
1.55
8.51
2.9
2.8
%
1.7
1.8
0.95
212
1445
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
96
507
1.94
8.30
1.3
1.3
—
—
—
0
0
(3004809) Band form neutrophils/100 leukocytes in Blood
53
222
2.43
8.19
3.0
3.7
%
0.6
1.4
2.56
45
187
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
470
3657
1.38
7.89
1.3
1.3
u/ml
1.6
1.5
0.06
121
958
(3004616) Nuclear Ab [Presence] in Serum
44
174
2.56
7.69
1.4
1.2
—
—
—
0
0
(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay
12
18
6.70
7.61
1.8
1.8
—
—
—
0
0
(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum
35
125
2.83
7.44
1.2
1.2
titre
215.0
250.0
0.10
12
24
(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection
17
37
4.63
7.40
1.2
1.5
—
—
—
0
0
(3015377) Calcium [Moles/volume] in Serum or Plasma
630
5171
1.32
7.34
3.1
3.4
mmol/l
2.4
2.4
0.18
560
4535
(3052851) Hemolysis interference index of Serum or Plasma
85
450
1.93
7.33
3.1
3.3
—
—
—
0
0
(40761535) Cells panel - Urine sediment
182
1201
1.57
7.16
4.0
3.3
—
—
—
0
0
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
552
4465
1.33
7.07
2.3
2.2
u/l
144.9
220.5
2.24
515
4211
(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
62
298
2.12
6.98
1.2
1.2
u/ml
2.2
4.9
—
5
25
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
233
1633
1.49
6.93
3.2
4.2
u/l
242.3
246.3
0.16
223
1544
(3023520) Reticulocytes [#/volume] in Blood
181
1202
1.56
6.93
2.8
2.7
e9/l
70.4
70.3
0.01
145
920
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
1580
14777
1.37
6.72
17.1
12.2
ml/min/173m2
85.0
83.1
2.61
1359
12105
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
335
2526
1.39
6.70
3.2
2.7
e6/l
0.8
1.1
3.27
208
1437
(3002621) Streptococcal DNAse B [Units/volume] in Serum
10
14
7.17
6.70
1.1
1.3
—
—
—
0
0
(3037121) Protein [Mass/volume] in Urine
95
538
1.81
6.67
2.9
3.4
g/l
0.2
0.3
1.64
42
230
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
74
387
1.95
6.64
1.3
1.2
u/ml
5.7
2.4
0.89
11
39
(3025941) Bacteria identified in Stool by Culture
138
869
1.63
6.61
1.3
1.2
—
—
—
0
0
(3013512) EKG study
529
4297
1.32
6.49
4.4
3.7
—
—
—
0
0
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
22
65
3.41
6.42
1.1
1.1
—
—
—
0
0
(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma
23
70
3.31
6.42
1.2
1.1
iu/ml
171.4
219.8
0.41
23
70
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
74
393
1.92
6.36
1.3
1.2
u/ml
5.6
11.7
0.75
16
68
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
503
4067
1.32
6.36
3.0
3.0
ng/l
1369.1
1277.9
0.14
427
3419
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
1338
12271
1.29
6.17
4.3
4.0
pmol/l
14.8
14.7
1.08
1216
11234
(3000060) B lymphocytes [#/volume] in Blood
17
43
3.98
6.17
2.1
2.1
e6/l
165.7
240.8
—
7
25
(3019150) Specific gravity of Urine by Refractometry
418
3305
1.34
6.15
5.0
3.9
kg/l
1.0
1.0
0.04
63
480
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
62
316
1.99
6.02
1.2
1.2
—
—
—
0
0
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
175
1195
1.51
5.92
3.2
2.9
ng/l
155.3
199.3
1.04
159
1081
(3008757) Leukocyte morphology finding [Identifier] in Blood
39
166
2.38
5.91
3.3
3.9
—
—
—
0
0
(3024474) Albumin [Mass/volume] in Cerebral spinal fluid
33
130
2.57
5.88
1.2
1.1
mg/l
311.0
252.9
0.24
26
111
(3012095) Magnesium [Moles/volume] in Serum or Plasma
317
2420
1.37
5.84
3.5
3.6
mmol/l
0.8
0.8
0.56
296
2268
(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection
9
7
12.91
5.58
1.1
1.0
—
—
—
0
0
(3030981) Hyaline casts [#/volume] in Urine by Automated count
119
755
1.61
5.57
3.1
2.7
e6/l
0.1
0.3
1.43
114
731
(3012516) Albumin [Mass/volume] in Urine
516
4254
1.29
5.54
3.8
3.3
mg/l
617.3
352.1
0.47
328
2681
(3051651) Icteric interference index of Serum or Plasma
27
99
2.75
5.53
4.1
3.8
—
—
—
0
0
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
31
123
2.55
5.46
1.5
1.2
—
—
—
0
0
(3007368) IgG [Mass/volume] in Cerebral spinal fluid
33
135
2.47
5.46
1.2
1.1
mg/l
40.4
39.8
0.04
22
108
(3007461) Platelets [#/volume] in Blood
1836
17771
1.62
5.42
31.2
19.5
e9/l
264.6
253.3
10.51
1812
17327
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
71
393
1.84
5.42
1.3
1.2
—
—
—
0
0
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
32
130
2.49
5.38
1.2
1.1
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
310
2394
1.35
5.29
2.0
1.8
—
—
—
0
0
(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid
27
102
2.67
5.25
1.2
1.1
u/l
1.3
1.1
0.36
14
49
(3024731) MCV [Entitic volume]
1836
17784
1.60
5.24
31.1
19.4
fl
91.0
90.8
1.42
1820
17544
(3019225) pH of Specimen
208
1507
1.43
5.21
4.3
4.1
—
—
—
0
0
(3035941) MCH [Entitic mass]
1836
17787
1.60
5.20
31.0
19.4
pg
30.2
30.2
0.24
1820
17545
(3026361) Erythrocytes [#/volume] in Blood
1836
17788
1.60
5.19
31.2
19.5
e12/l
4.5
4.5
2.48
1812
17302
(3020779) Urea [Moles/volume] in Serum or Plasma
184
1304
1.45
5.19
6.9
7.7
mmol/l
9.1
9.3
0.17
176
1249
(3009508) Creatinine [Moles/volume] in Urine
558
4680
1.27
5.17
3.8
3.2
mmol/l
7.1
7.6
1.97
482
3950
(1761482) Bacteria [#/volume] in Urine by Culture
68
378
1.83
5.14
6.2
4.3
—
—
—
0
0
(3010813) Leukocytes [#/volume] in Blood
1836
17792
1.60
5.13
31.3
19.5
e9/l
7.0
6.7
2.06
1810
17306
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
388
3109
1.31
5.12
1.7
1.5
—
—
—
0
0
(3000963) Hemoglobin [Mass/volume] in Blood
1836
17795
1.59
5.09
31.4
19.6
g/l
134.2
135.4
2.95
1823
17552
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
1544
14559
1.30
4.97
5.2
4.7
mu/l
1.9
2.0
0.13
1418
13388
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
28
111
2.54
4.97
1.2
1.2
—
—
—
0
0
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
140
949
1.51
4.93
3.3
4.0
kpa
5.1
5.2
0.94
128
892
(3036603) Volume of Urine
26
100
2.62
4.90
2.6
1.5
ml
2002.7
1968.8
—
10
16
(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay
17
51
3.35
4.88
1.3
1.0
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
55
293
1.90
4.76
2.0
1.7
—
—
—
0
0
(3009343) pH of Capillary blood
138
942
1.50
4.71
3.3
4.0
ph
7.4
7.4
0.69
20
114
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
357
2863
1.30
4.66
3.8
3.6
ng/l
203.8
455.8
1.37
267
2130
(3020682) Albumin/Creatinine [Ratio] in Urine
533
4496
1.26
4.62
4.6
4.0
mg/mmol
15.8
9.0
1.04
339
2840
(40767503) Oxygen content in Capillary blood by calculation
53
283
1.90
4.57
3.0
2.5
%
16.0
16.4
0.37
27
148
(3042631) Mycobacterium sp identified in Specimen
39
187
2.11
4.53
2.4
2.7
—
—
—
0
0
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
133
910
1.50
4.50
3.3
4.0
mmol/l
1.7
1.8
0.18
95
683
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
301
2369
1.32
4.49
3.5
2.9
e6/l
3.2
2.7
0.34
174
1291
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
417
3440
1.27
4.34
1.8
1.7
mg/l
1.7
1.1
0.91
314
2585
(3006184) Hemoglobin [Mass/volume] in Capillary blood
55
303
1.84
4.33
2.3
2.3
g/l
127.3
130.0
0.51
40
229
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
31
138
2.27
4.32
1.4
1.3
—
—
—
0
0
(3047181) Lactate [Moles/volume] in Blood
76
461
1.68
4.30
5.3
6.3
mmol/l
1.4
1.3
0.50
64
396
(40760888) Immunoglobulin light chains.free panel - Serum
57
319
1.81
4.27
2.4
3.8
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
52
283
1.86
4.26
1.5
1.5
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
105
692
1.55
4.24
2.1
1.9
—
—
—
0
0
(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum
70
417
1.70
4.24
2.4
3.6
ratio
1.3
1.5
—
6
40
(40768797) Stomach Pathology biopsy report
271
2120
1.32
4.22
1.3
1.2
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
71
427
1.69
4.16
1.1
1.1
—
—
—
0
0
(3010144) Erythrocytes [#/volume] in Synovial fluid
32
147
2.20
4.15
1.3
1.4
e6/l
10717.9
84326.8
0.85
24
96
(3005322) IgE [Units/volume] in Serum or Plasma
145
1028
1.44
4.12
1.3
1.3
u/ml
233.0
204.9
0.12
133
950
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
71
429
1.68
4.09
2.4
3.6
mg/l
30.8
86.4
1.11
53
355
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
58
334
1.76
3.98
1.3
1.4
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
67
402
1.69
3.97
1.2
1.3
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
207
1572
1.35
3.94
3.5
3.1
—
—
—
0
0
(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma
15
48
3.14
3.93
1.3
1.1
—
—
—
0
0
(3006442) Creatine [Moles/volume] in Serum or Plasma
26
112
2.34
3.92
1.4
1.4
—
71.5
—
0
12
(3034860) Kappa light chains.free [Mass/volume] in Serum
70
427
1.66
3.91
2.4
3.6
mg/l
56.7
74.1
0.41
52
353
(3045424) Erythrocytes [Presence] in Urine
48
263
1.85
3.88
1.8
1.5
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
71
436
1.65
3.87
1.2
1.3
—
—
—
0
0
(3039000) Anion gap in Blood
57
330
1.75
3.85
5.8
7.1
mmol/l
12.4
11.3
1.49
51
292
(3018572) Chloride [Moles/volume] in Blood
57
331
1.74
3.81
5.8
7.1
mmol/l
104.9
105.3
0.27
51
293
(3007930) Methemoglobin/Hemoglobin.total in Blood
90
589
1.55
3.78
5.7
5.2
%
0.9
0.9
0.08
84
545
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
26
115
2.28
3.71
1.4
1.9
—
—
—
0
0
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
79
504
1.59
3.71
2.2
2.5
g/l
11.1
10.4
0.63
67
429
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
825
7408
1.20
3.70
4.5
4.0
—
—
—
0
0
(4027681)
25
109
2.31
3.69
1.5
1.2
—
—
—
0
0
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
15
50
3.02
3.69
1.0
1.2
—
—
—
0
0
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
194
1475
1.35
3.67
2.5
2.3
g/l
0.2
0.2
0.53
186
1378
(3029075) Extractable nuclear Ab panel - Serum
14
45
3.13
3.65
1.0
1.0
—
—
—
0
0
(3036670) Protein [Mass/volume] in Synovial fluid
14
45
3.13
3.65
1.4
1.2
g/l
35.6
37.2
—
7
25
(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma
22
91
2.43
3.64
1.3
1.5
u/l
5.1
6.9
1.12
16
75
(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum
12
35
3.44
3.62
1.4
1.2
—
—
—
0
0
(3017354) Segmented neutrophils/100 leukocytes in Blood
29
136
2.15
3.62
2.8
3.3
%
54.4
54.8
0.04
23
100
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
122
864
1.44
3.52
1.8
1.4
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
33
165
2.02
3.50
1.1
1.0
—
—
—
0
0
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
83
544
1.55
3.49
2.1
2.4
g/l
4.1
3.8
0.92
58
394
(3026470) Cobalt [Mass/volume] in Blood
21
87
2.43
3.47
2.2
2.0
ug/l
2.6
2.9
0.10
16
75
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
83
545
1.55
3.46
2.1
2.4
—
—
—
0
0
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
83
545
1.55
3.46
2.1
2.4
g/l
7.6
7.3
0.94
60
416
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
224
1755
1.31
3.46
3.4
2.9
umol/l
8.4
7.9
0.10
192
1518
(3000330) Specific gravity of Urine by Test strip
110
767
1.46
3.45
5.2
3.3
—
—
—
0
0
(40768446) Kidney Pathology biopsy report
16
58
2.77
3.42
1.4
1.5
—
—
—
0
0
(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay
73
467
1.59
3.41
2.5
2.7
g/l
3.7
3.6
0.23
63
441
(36660697) Celiac disease serology panel - Serum
172
1301
1.35
3.38
1.2
1.2
—
—
—
0
0
(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma
9
18
5.02
3.37
1.1
1.1
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
56
338
1.68
3.30
1.5
1.5
—
—
—
0
0
(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum
14
48
2.93
3.30
1.0
1.2
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
1550
14818
1.23
3.27
21.6
14.2
%
39.0
39.9
2.68
1050
10985
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
56
339
1.67
3.27
1.3
1.2
—
—
—
0
0
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
60
370
1.64
3.27
1.5
1.6
e6/l
955.3
1363.8
0.21
51
304
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
60
370
1.64
3.27
1.4
1.5
e6/l
8.3
10.3
0.20
49
292
(3044927) Protein electrophoresis panel - Urine
30
149
2.03
3.26
1.2
1.2
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
1720
16642
1.30
3.25
19.0
12.5
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
703
6278
1.19
3.24
2.2
2.1
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
59
363
1.64
3.24
1.4
1.6
—
—
—
0
0
(3018677) aPTT in Platelet poor plasma by Coagulation assay
279
2273
1.27
3.19
2.0
2.2
s
29.5
29.7
0.21
263
2200
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
36
193
1.88
3.16
1.1
1.1
—
—
—
0
0
(3012501) Base excess in Blood by calculation
52
312
1.69
3.15
3.1
4.3
mmol/l
2.6
2.6
0.03
36
207
(3017704) Immunofixation for Urine
19
79
2.42
3.14
1.3
1.6
—
—
—
0
0
(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood
87
592
1.49
3.11
5.7
5.2
%
1.6
1.6
0.02
81
547
(3021960) Folate [Moles/volume] in Serum or Plasma
408
3476
1.22
3.10
1.7
1.5
nmol/l
21.4
20.9
0.24
350
2964
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
53
321
1.67
3.10
1.3
1.2
u/ml
240.0
259.7
0.23
21
193
(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot
12
39
3.09
3.09
1.2
1.1
—
—
—
0
0
(42529582) MDA5 Ab [Presence] in Serum by Line blot
12
39
3.09
3.09
1.2
1.1
—
—
—
0
0
(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot
12
39
3.09
3.09
1.2
1.1
—
—
—
0
0
(3013637) Mi-2 Ab [Presence] in Serum
12
39
3.09
3.09
1.2
1.1
—
—
—
0
0
(3026480) Teichoate Ab [Titer] in Serum
6
8
7.52
3.05
1.2
1.0
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
1137
10601
1.18
3.05
3.6
3.1
u/l
48.1
46.8
0.17
1054
9927
(3008152) Bicarbonate [Moles/volume] in Arterial blood
124
906
1.39
3.04
7.3
6.9
mmol/l
24.4
24.6
0.23
110
843
(3016018) Differential panel - Cerebral spinal fluid
32
168
1.92
3.00
1.4
1.6
—
—
—
0
0
(3015235) Bicarbonate [Moles/volume] in Capillary blood
56
348
1.63
2.98
2.8
3.3
mmol/l
24.5
25.1
0.43
50
310
(3012320) Pathologist interpretation of Cerebral spinal fluid tests
11
35
3.16
2.93
1.2
1.3
—
—
—
0
0
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
84
576
1.48
2.91
2.6
2.0
ug/l
3.0
1.8
0.35
79
505
(3019060) Gas panel - Arterial blood
128
948
1.37
2.91
4.8
4.8
—
—
—
0
0
(3024263) Appearance of Synovial fluid
18
76
2.38
2.89
4.8
1.8
—
—
—
0
0
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
15
58
2.60
2.87
1.1
1.2
—
—
—
0
0
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
22
102
2.17
2.87
1.3
1.1
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
207
1648
1.29
2.86
1.9
1.7
—
—
—
0
0
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
34
186
1.84
2.84
1.1
1.1
—
—
—
0
0
(3028433) Virus identified in Specimen by Culture
13
47
2.78
2.81
1.1
1.4
—
—
—
0
0
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
20
90
2.23
2.80
1.3
1.0
—
—
—
0
0
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
20
90
2.23
2.80
1.3
1.0
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
34
187
1.83
2.79
1.2
1.6
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
106
767
1.40
2.78
7.2
10.6
—
—
—
0
0
(3006922) Hepatitis E virus Ab [Presence] in Serum
21
97
2.18
2.77
1.3
1.0
—
—
—
0
0
(3010421) pH of Blood
60
387
1.57
2.77
3.1
4.0
ph
7.4
7.4
0.56
52
308
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
88
616
1.45
2.76
1.9
1.9
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
69
460
1.52
2.75
3.1
3.2
u/ml
0.4
0.4
0.52
35
261
(3013166) Neutrophils/100 leukocytes in Synovial fluid
12
42
2.87
2.75
1.3
1.4
%
37.7
51.0
0.64
12
37
(3036071) Salmonella sp Ab [Titer] in Serum
15
60
2.51
2.70
1.1
1.1
—
—
—
0
0
(3001964) Herpes simplex virus Ag [Presence] in Specimen
11
37
2.98
2.69
1.1
2.0
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
42
251
1.69
2.63
3.0
2.9
—
—
—
0
0
(3044889) 12 lead EKG panel
1148
10778
1.16
2.62
4.0
3.6
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
106
777
1.39
2.59
2.2
2.3
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
43
260
1.67
2.58
3.1
3.0
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
42
254
1.67
2.53
1.1
1.3
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
55
356
1.56
2.52
1.4
1.7
—
—
—
0
0
(1616796) Gas panel - Central venous blood
48
303
1.60
2.45
3.9
3.8
—
—
—
0
0
(3006270) Folate [Moles/volume] in Blood
24
123
1.96
2.45
1.3
1.1
nmol/l
359.8
388.8
0.31
18
108
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
14
57
2.47
2.45
3.3
3.9
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
147
1144
1.31
2.44
1.1
1.2
iu/ml
112.2
144.3
0.42
56
442
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
29
159
1.84
2.44
1.4
1.7
—
—
—
0
0
(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay
10
34
2.95
2.41
2.1
1.1
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
79
558
1.43
2.40
1.7
1.7
—
—
—
0
0
(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
9
27
3.34
2.39
6.8
5.3
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
41
251
1.65
2.37
1.3
1.6
—
—
—
0
0
(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay
5
8
6.26
2.37
1.0
1.1
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
204
1664
1.25
2.34
2.0
1.7
—
—
—
0
0
(3000012) Reticulocyte production index
16
72
2.23
2.27
1.1
1.6
—
—
—
0
0
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
73
514
1.44
2.27
2.1
2.4
g/l
3.0
3.1
0.37
58
402
(3016650) Hepatitis A virus Ab [Presence] in Serum
43
270
1.61
2.27
1.1
1.1
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
149
1175
1.29
2.26
2.8
2.6
ml/min/173m2
63.3
68.1
0.72
57
477
(3051611) Lipemic interference index of Serum or Plasma
28
156
1.81
2.26
4.7
3.5
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
76
540
1.42
2.26
1.3
1.3
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
1129
10649
1.14
2.25
3.2
3.1
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
17
79
2.16
2.25
1.2
1.8
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
17
79
2.16
2.25
1.2
1.8
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
17
79
2.16
2.25
1.2
1.8
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
17
79
2.16
2.25
1.2
1.8
—
—
—
0
0
(3005895) Myoglobin [Mass/volume] in Serum or Plasma
70
491
1.44
2.23
2.2
2.3
ug/l
473.2
449.3
0.04
63
458
(3015956) Eosinophils/100 leukocytes in Blood by Manual count
5
9
5.57
2.21
1.8
1.8
%
0.2
2.6
—
5
9
(3022217) INR in Platelet poor plasma by Coagulation assay
217
1798
1.23
2.18
27.1
23.6
inr
1.3
1.3
0.08
41
253
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
18
87
2.08
2.17
5.9
6.8
—
—
—
0
0
(3017817) Protein [Mass] in Urine collected for unspecified duration
24
129
1.87
2.17
2.1
2.2
—
—
—
0
0
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
87
639
1.38
2.15
1.9
2.3
u/l
614.6
3558.9
2.99
33
254
(21494755) Public health laboratory ask at order entry panel
128
1626
0.77
2.14
1.2
1.3
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
35
212
1.66
2.14
1.3
1.3
—
—
—
0
0
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
24
130
1.86
2.12
1.3
1.4
—
—
—
0
0
(3002256) Pathology report gross observation
235
1969
1.22
2.12
1.3
1.3
—
—
—
0
0
(3004490) Bicarbonate [Moles/volume] standard in Capillary blood
85
624
1.38
2.11
3.5
4.3
mmol/l
24.7
24.9
0.28
77
587
(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood
19
95
2.01
2.10
3.5
2.8
%
53.3
41.7
—
10
27
(3033705) Calcium.ionized [Moles/volume] in Venous blood
30
175
1.73
2.10
3.9
2.5
—
—
—
0
0
(3051014) Leukocytes [#/area] in Urine sediment by Automated count
23
124
1.87
2.07
1.6
2.1
u/field
2.7
2.2
0.19
11
57
(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum
5
10
5.01
2.07
1.2
1.5
—
—
—
0
0
(3022621) pH of Urine by Test strip
129
1013
1.29
2.04
3.0
2.8
—
—
—
0
0
(3022313) Gas panel - Capillary blood
94
708
1.34
2.00
3.5
4.1
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
30
178
1.70
1.99
1.2
1.6
—
—
—
0
0
(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence
18
91
1.99
1.95
1.3
1.3
—
885.6
—
0
9
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
27
157
1.73
1.93
1.1
1.1
—
—
—
0
0
(3035880) pH of Pleural fluid
15
71
2.12
1.92
1.1
1.2
—
—
—
0
0
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
313
2720
1.18
1.92
2.6
3.0
mmol/l
2.5
2.4
0.14
279
2391
(3003396) Base excess in Arterial blood by calculation
198
1650
1.22
1.90
6.3
7.7
mmol/l
1.2
1.2
0.06
139
1292
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
19
99
1.93
1.90
1.0
1.2
—
—
—
0
0
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
18
92
1.97
1.90
1.4
1.3
—
—
—
0
0
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
86
646
1.35
1.88
1.5
1.9
g/l
1.5
1.5
0.17
73
566
(3034274) Bile acid [Moles/volume] in Serum --fasting
33
205
1.62
1.86
2.1
2.2
umol/l
5.8
7.0
0.29
21
150
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
41
269
1.54
1.85
1.1
1.1
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
38
245
1.56
1.85
1.1
1.1
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
31
192
1.62
1.78
1.4
1.5
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
31
192
1.62
1.78
1.4
1.5
—
—
—
0
0
(3014576) Chloride [Moles/volume] in Serum or Plasma
216
1832
1.20
1.75
6.8
7.0
mmol/l
104.1
104.3
0.25
210
1791
(3023183) Ammonium ion [Moles/volume] in Plasma
47
322
1.47
1.75
2.5
3.0
umol/l
35.3
35.0
0.02
36
274
(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay
6
18
3.34
1.74
1.0
1.1
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
544
4957
1.14
1.74
2.5
2.4
—
—
—
0
0
(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)
8
30
2.67
1.72
1.0
1.2
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
31
194
1.61
1.72
1.4
1.4
—
—
—
0
0
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
18
96
1.88
1.70
1.4
1.1
—
—
—
0
0
(3016502) Oxygen saturation in Arterial blood
176
1469
1.22
1.69
6.7
8.1
%
95.9
95.7
0.18
168
1414
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
31
195
1.60
1.69
1.4
1.4
—
—
—
0
0
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
33
211
1.57
1.68
1.2
1.2
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
27
164
1.66
1.68
1.6
1.8
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
31
196
1.59
1.66
1.4
1.4
—
—
—
0
0
(3010254) Herpes simplex virus identified in Specimen by Organism specific culture
8
31
2.59
1.66
1.4
1.0
—
—
—
0
0
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
72
539
1.35
1.64
3.1
3.5
u/ml
308.5
2552.4
0.64
59
459
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
12
56
2.15
1.61
2.4
2.7
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
62
456
1.37
1.59
2.0
1.8
—
—
—
0
0
(3008401) Mugwort IgE Ab [Units/volume] in Serum
17
300
0.56
1.59
1.1
1.1
u/ml
0.3
1.5
—
7
137
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
26
160
1.63
1.56
1.3
1.7
—
—
—
0
0
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
173
1455
1.21
1.55
3.0
2.4
u/l
52.6
72.0
0.24
143
1255
(3023323) Follitropin [Units/volume] in Serum or Plasma
98
775
1.28
1.53
1.3
1.4
iu/l
30.3
27.2
0.40
84
641
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
38
257
1.49
1.53
1.3
1.2
u/ml
2.5
3.7
0.36
14
83
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
126
1534
0.81
1.52
2.0
1.7
—
—
—
0
0
(1617658) Protocol used for examination of sentinel lymph nodes
6
144
0.41
1.51
1.2
1.1
—
—
—
0
0
(3009214) Lutropin [Units/volume] in Serum or Plasma
64
478
1.35
1.50
1.2
1.5
u/l
13.6
9.6
0.93
55
379
(3034426) Prothrombin time (PT)
11
51
2.16
1.50
1.2
1.3
—
—
—
0
0
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
63
470
1.35
1.49
2.4
2.6
g/l
0.6
1.1
0.88
52
416
(3012544) pH of Venous blood
170
1435
1.20
1.48
5.1
3.9
—
7.4
—
0
6
(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma
24
147
1.64
1.47
4.9
4.5
u/ml
57.1
103.6
—
9
43
(3021447) Carbon dioxide [Partial pressure] in Venous blood
167
1408
1.20
1.47
5.1
3.9
kpa
5.9
5.9
0.20
161
1365
(3037756) Immunofixation for Serum or Plasma
42
293
1.44
1.46
1.4
1.7
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
33
219
1.52
1.46
1.3
1.4
—
—
—
0
0
(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis
58
429
1.36
1.46
2.4
2.4
g/l
38.8
37.7
0.94
51
373
(3002173) Hemoglobin [Mass/volume] in Arterial blood
161
1355
1.21
1.45
7.3
8.4
g/l
120.6
121.5
0.21
153
1300
(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine
6
22
2.73
1.43
1.8
1.5
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
73
561
1.31
1.43
1.6
1.4
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
30
196
1.54
1.43
1.4
1.4
—
—
—
0
0
(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis
53
388
1.38
1.42
2.5
2.5
g/l
0.0
0.0
0.00
47
359
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
18
103
1.75
1.41
1.3
1.2
—
—
—
0
0
(4035726)
158
1332
1.20
1.40
1.4
1.4
—
—
—
0
0
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
120
986
1.23
1.38
3.8
3.2
pmol/l
4.4
4.5
1.01
107
869
(3013293) Extractable nuclear Ab [Presence] in Serum
6
23
2.61
1.36
1.3
1.8
—
—
—
0
0
(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid
6
23
2.61
1.36
1.0
1.2
—
—
—
0
0
(3002032) Base excess in Venous blood by calculation
165
1401
1.19
1.36
5.4
3.9
mmol/l
2.1
1.9
0.34
136
1126
(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis
53
392
1.36
1.35
2.5
2.4
g/l
0.0
0.0
0.00
47
360
(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis
56
418
1.35
1.35
2.4
2.4
g/l
0.0
0.0
0.72
50
385
(3028707) Methadone [Presence] in Urine by Screen method
19
309
0.61
1.34
3.9
2.6
—
—
—
0
0
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
10
47
2.13
1.33
2.6
2.6
—
—
—
0
0
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
10
47
2.13
1.33
2.6
2.6
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
66
506
1.32
1.33
1.9
1.8
—
—
—
0
0
(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood
81
639
1.28
1.33
7.4
3.7
%
49.8
48.1
0.27
81
629
(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
11
54
2.04
1.33
1.0
1.1
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
22
136
1.62
1.32
1.2
1.6
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
22
136
1.62
1.32
1.2
1.6
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
22
136
1.62
1.32
1.2
1.6
—
—
—
0
0
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
191
1649
1.18
1.31
6.6
7.7
kpa
5.0
5.1
0.79
177
1576
(3027801) Oxygen [Partial pressure] in Arterial blood
191
1650
1.17
1.30
6.6
7.7
kpa
12.0
12.4
0.51
177
1580
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
16
91
1.76
1.29
1.0
1.1
—
—
—
0
0
(3035933) Granulocytes/100 leukocytes in Blood
10
48
2.09
1.27
3.9
1.4
—
—
—
0
0
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
10
48
2.09
1.27
1.5
1.3
ug/l
7.5
8.9
—
10
48
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
171
1467
1.18
1.27
4.0
4.3
ug/l
26.2
20.0
0.15
134
1194
(40768441) Liver Pathology biopsy report
20
122
1.65
1.27
1.6
1.4
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
204
1776
1.17
1.27
8.6
6.6
—
—
—
0
0
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
36
252
1.44
1.26
1.3
1.2
u/ml
2.8
4.7
0.88
15
107
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
445
4083
1.12
1.25
4.9
4.7
ug/l
3.9
2.6
0.50
396
3673
(3036048) Francisella tularensis Ab [Titer] in Serum
8
36
2.23
1.24
1.0
1.1
—
—
—
0
0
(3003888) Timothy IgE Ab [Units/volume] in Serum
20
314
0.63
1.23
1.1
1.1
u/ml
4.0
6.6
—
9
175
(3049717) Cytology report of Urine Cyto stain
67
522
1.29
1.22
2.8
2.6
—
—
—
0
0
(3037692) Legionella sp identified in Specimen by Organism specific culture
10
49
2.05
1.22
1.0
1.9
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
28
188
1.50
1.21
1.4
1.5
—
—
—
0
0
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
14
78
1.80
1.21
1.8
1.8
—
—
—
0
0
(44790047)
27
181
1.50
1.18
1.4
1.6
—
—
—
0
0
(44790049)
27
181
1.50
1.18
1.4
1.6
—
—
—
0
0
(44790048)
27
181
1.50
1.18
1.4
1.6
—
—
—
0
0
(44806118)
27
181
1.50
1.18
1.4
1.6
—
—
—
0
0
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
26
173
1.51
1.18
1.1
1.1
—
—
—
0
0
(4146454)
24
157
1.54
1.17
2.8
2.6
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
28
190
1.48
1.16
2.2
2.7
—
—
—
0
0
(3033658) Prothrombin time (PT) actual/Normal
425
3908
1.11
1.15
4.6
3.9
%
92.4
90.9
0.58
410
3804
(3035457) Cefaclor IgE Ab [Units/volume] in Serum
5
20
2.50
1.15
1.0
1.1
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
42
309
1.37
1.14
1.3
1.3
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
42
309
1.37
1.14
1.3
1.3
—
—
—
0
0
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
17
103
1.66
1.12
1.2
1.2
—
—
—
0
0
(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay
7
30
2.34
1.12
1.0
1.2
—
—
—
0
0
(3010726) Horse dander IgE Ab [Units/volume] in Serum
19
294
0.64
1.12
1.0
1.1
u/ml
0.6
3.2
—
5
71
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
30
209
1.44
1.10
1.5
1.6
—
—
—
0
0
(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)
16
96
1.67
1.10
1.1
1.1
ratio
1.1
1.0
—
9
38
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
24
160
1.51
1.09
1.5
1.8
—
—
—
0
0
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
17
104
1.64
1.09
1.2
1.2
—
—
—
0
0
(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma
5
21
2.38
1.09
1.4
1.4
ng/l
46.0
96.1
—
5
21
(3014133) Dog dander IgE Ab [Units/volume] in Serum
14
231
0.60
1.08
1.0
1.1
u/ml
2.6
3.1
—
8
92
(3001019) Free T4 and TSH panel - Serum or Plasma
73
901
0.80
1.07
1.8
1.7
—
—
—
0
0
(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay
17
105
1.62
1.06
1.2
1.1
u/ml
2.2
2.1
—
5
7
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
53
410
1.30
1.05
2.2
1.9
iu/l
5.2
4.8
0.08
19
146
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
24
347
0.69
1.03
1.0
1.1
u/ml
4.9
2.1
—
9
151
(3047166) Epithelial cells [#/area] in Urine sediment by Automated count
5
22
2.28
1.03
2.6
2.8
u/field
0.4
0.7
—
5
22
(40768806) Pleura Pathology biopsy report
21
138
1.53
1.03
1.4
1.6
—
—
—
0
0
(40761539) Cells [Type] in Urine sediment by Light microscopy
7
34
2.06
1.03
1.1
1.2
—
—
—
0
0
(3042733) HLA Ab [Presence] in Serum
9
48
1.88
1.00
4.7
4.4
—
—
—
0
0
(3000570) Elastase.pancreatic [Mass/mass] in Stool
56
440
1.28
1.00
1.4
1.5
ug/g
239.2
293.9
1.47
41
260
(3028308) Erythrocytes [#/volume] in Pleural fluid
20
131
1.53
1.00
1.3
1.4
e6/l
7742.7
31310.0
—
7
73
(3005570) Glucose [Moles/volume] in Urine
24
164
1.47
0.99
2.5
2.2
—
—
—
0
0
(3042585) Pyridoxine [Moles/volume] in Serum or Plasma
9
49
1.84
0.98
1.1
1.3
nmol/l
93.9
117.1
—
9
36
(3051101) Glucose [Moles/volume] in Cord blood
5
23
2.18
0.98
4.6
6.3
—
—
—
0
0
(3003181) Sodium [Moles/volume] in Urine
37
275
1.35
0.97
1.2
1.5
mmol/l
58.2
63.2
0.50
30
224
(3012441) Differential panel - Pleural fluid
20
132
1.52
0.97
1.3
1.4
—
—
—
0
0
(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection
9
50
1.80
0.96
1.3
1.2
—
—
—
0
0
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
12
69
1.74
0.96
2.5
2.7
—
—
—
0
0
(4094501)
29
399
0.72
0.96
1.0
1.1
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
35
259
1.36
0.95
1.5
1.8
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
1456
14235
1.09
0.93
6.4
5.4
mmol/mol
39.5
39.4
0.17
1346
13234
(3040151) Glucose [Moles/volume] in Capillary blood
22
150
1.47
0.93
4.0
7.0
mmol/l
7.3
7.2
0.05
22
123
(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
9
52
1.73
0.92
1.0
1.1
—
—
—
0
0
(3023199) Leukocytes [#/volume] in Pleural fluid
22
151
1.46
0.90
1.3
1.3
e6/l
1242.4
1695.9
0.25
14
102
(3045683) HLA typing for celiac disease panel - Blood or Tissue
16
102
1.57
0.90
1.1
1.0
—
—
—
0
0
(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting
45
350
1.29
0.89
4.8
2.3
nmol/l
0.8
0.8
0.06
39
293
(3006576) Bicarbonate [Moles/volume] in Blood
8
42
1.91
0.88
4.0
6.7
mmol/l
26.6
25.4
—
8
37
(3001788) Aldosterone [Moles/volume] in Serum or Plasma
25
177
1.42
0.88
1.1
1.4
pmol/l
297.4
317.1
0.11
20
140
(3045788) Cell count panel - Pleural fluid
18
119
1.52
0.88
1.4
1.4
—
—
—
0
0
(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid
6
30
2.00
0.87
1.0
1.0
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
440
4116
1.09
0.85
1.9
1.7
mmol/l
1.4
1.4
0.44
372
3493
(3008536) Aspergillus sp Ab [Presence] in Serum
6
31
1.94
0.84
2.5
1.5
—
—
—
0
0
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
14
88
1.60
0.84
1.4
1.5
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
20
137
1.46
0.84
3.0
3.8
—
—
—
0
0
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
20
137
1.46
0.84
1.2
1.0
—
—
—
0
0
(3041806) Other cells [#/volume] in Blood by Manual count
10
57
1.76
0.83
1.9
1.4
—
—
—
0
0
(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay
58
471
1.24
0.83
2.7
2.6
%
197.0
183.7
0.47
53
449
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
11
65
1.70
0.82
1.3
1.9
—
—
—
0
0
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
11
65
1.70
0.82
1.1
1.2
—
—
—
0
0
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
11
65
1.70
0.82
1.3
1.9
—
—
—
0
0
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
11
65
1.70
0.82
1.3
1.9
—
—
—
0
0
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
11
65
1.70
0.82
1.1
1.0
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
89
1042
0.85
0.80
1.5
1.4
—
—
—
0
0
(3020650) Glucose [Presence] in Urine
8
47
1.70
0.80
1.8
1.7
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
56
455
1.24
0.80
1.4
1.2
—
—
—
0
0
(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method
25
181
1.39
0.80
2.5
2.4
mg/l
19.1
27.3
0.76
12
52
(3008116) Ketones [Moles/volume] in Urine by Test strip
6
33
1.82
0.79
1.7
1.3
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
33
251
1.32
0.78
1.1
1.1
—
—
—
0
0
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
12
74
1.63
0.78
1.4
1.6
—
—
—
0
0
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
12
74
1.63
0.78
1.4
1.6
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
205
1856
1.12
0.78
4.4
4.4
%
31.8
32.1
0.15
139
1280
(42529406) Shigella sp [Presence] in Stool by Culture
57
466
1.23
0.77
1.4
1.2
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
45
358
1.26
0.77
1.5
1.5
—
—
—
0
0
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
5
100
0.50
0.77
2.4
1.7
—
—
—
0
0
(4306422)
32
243
1.32
0.77
1.3
1.2
—
—
—
0
0
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
62
512
1.22
0.77
1.3
1.3
miu/ml
168.8
230.4
0.51
21
247
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
72
604
1.20
0.76
1.5
1.7
—
—
—
0
0
(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma
6
34
1.77
0.76
1.2
3.1
—
—
—
0
0
(40768795) Lymph node Pathology biopsy report
19
132
1.44
0.76
1.3
1.2
—
—
—
0
0
(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
9
53
1.70
0.75
1.0
1.1
—
—
—
0
0
(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid
9
53
1.70
0.75
1.0
1.1
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
56
459
1.23
0.75
1.4
1.2
—
—
—
0
0
(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid
9
54
1.67
0.74
1.0
1.1
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
31
237
1.31
0.72
1.8
1.6
—
—
—
0
0
(3024354) Oxygen [Partial pressure] in Venous blood
133
1180
1.14
0.71
5.1
3.3
kpa
4.4
4.6
0.40
128
1143
(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid
5
26
1.93
0.70
1.0
1.1
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
1565
15405
1.08
0.70
4.6
4.2
mmol/l
1.5
1.5
0.43
1434
14273
(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method
62
519
1.20
0.69
2.2
2.4
%
95.0
91.5
0.48
54
487
(3052592) Norovirus Ag [Presence] in Stool
5
27
1.85
0.68
1.0
1.4
—
—
—
0
0
(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid
5
27
1.85
0.68
1.0
1.1
—
—
—
0
0
(3016293) Bicarbonate [Moles/volume] in Serum or Plasma
104
912
1.15
0.67
6.5
8.0
mmol/l
24.3
24.9
0.89
104
907
(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay
32
249
1.29
0.67
1.1
1.1
u/ml
4.4
1.9
0.77
15
113
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
5
91
0.55
0.67
1.0
1.1
—
—
—
0
0
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
5
94
0.53
0.66
1.8
1.8
—
—
—
0
0
(3013247) Albumin in CSF/Albumin in Serum or Plasma
5
28
1.79
0.66
1.0
1.0
mg/g
4.6
6.0
—
5
28
(3002619) Bacteria identified in Specimen by Culture
5
28
1.79
0.66
1.0
1.1
—
—
—
0
0
(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay
57
476
1.20
0.66
1.0
1.1
u/ml
2.3
5.0
—
7
56
(3012565) Volume of 24 hour Urine
12
78
1.54
0.65
1.6
3.0
ml
2287.5
1963.2
0.45
12
71
(3035637) Corticotropin [Mass/volume] in Plasma
25
189
1.33
0.64
1.8
1.6
—
—
—
0
0
(3027456) Digoxin [Moles/volume] in Serum or Plasma
22
292
0.75
0.63
2.9
3.3
nmol/l
0.7
0.8
1.21
17
230
(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum
18
129
1.40
0.63
1.4
1.3
u/ml
4.0
0.7
—
7
60
(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation
38
306
1.25
0.62
2.2
1.9
pmol/l
187.0
209.8
0.70
38
289
(3051593) INR in Capillary blood by Coagulation assay
8
50
1.60
0.61
13.3
12.1
—
—
—
0
0
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
16
113
1.42
0.61
1.3
1.2
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
1573
15512
1.07
0.60
4.6
4.2
mmol/l
4.7
4.7
0.39
1452
14451
(21494890) Protein electrophoresis panel - 24 hour Urine
20
148
1.36
0.59
2.4
2.0
—
—
—
0
0
(3024471) HLA-A [Type]
8
53
1.51
0.58
1.0
1.0
—
—
—
0
0
(40760435) Tropomyosin IgE Ab [Units/volume] in Serum
0
23
0.00
0.58
0.0
1.0
—
—
—
0
0
(3014891) Appearance of Pleural fluid
0
23
0.00
0.58
0.0
1.7
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
44
364
1.21
0.58
2.7
2.1
—
—
—
0
0
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
11
73
1.51
0.56
3.7
3.9
—
—
—
0
0
(3015183) Erythrocyte sedimentation rate
5
88
0.57
0.56
1.2
1.2
—
—
—
0
0
(3015076) Soybean IgE Ab [Units/volume] in Serum
5
89
0.56
0.56
1.0
1.0
—
6.2
—
0
13
(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma
13
90
1.45
0.55
1.1
1.2
u/l
89.0
84.2
0.07
13
79
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
31
248
1.25
0.55
1.1
1.1
—
—
—
0
0
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
15
108
1.39
0.53
1.5
1.6
—
—
—
0
0
(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay
30
241
1.25
0.52
1.1
1.1
%
124.4
116.0
0.58
25
223
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
9
63
1.43
0.52
1.1
1.3
—
—
—
0
0
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
9
63
1.43
0.52
1.1
1.3
—
—
—
0
0
(3048879) Bone marrow aspiration report
6
40
1.50
0.51
1.3
2.2
—
—
—
0
0
(3024889) Methemoglobin/Hemoglobin.total in Venous blood
76
668
1.14
0.51
3.6
2.8
%
0.7
0.7
0.03
76
647
(3024928) Oxygen saturation in Venous blood
25
314
0.79
0.51
3.3
3.2
—
—
—
0
0
(4015189)
7
45
1.56
0.49
1.3
2.7
—
—
—
0
0
(4034850)
42
496
0.84
0.48
11.5
9.0
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
35
290
1.21
0.47
1.7
1.7
—
—
—
0
0
(3035320) C reactive protein [Mass/volume] in Body fluid
15
112
1.34
0.44
2.1
2.0
—
—
—
0
0
(3004451) EKG impression Narrative
10
69
1.45
0.44
1.2
1.2
—
—
—
0
0
(3021387) Prolactin [Units/volume] in Serum or Plasma
71
630
1.13
0.44
1.6
1.6
mu/l
363.7
298.3
0.50
66
574
(1761868) Lipid panel - Serum or Plasma
557
5766
0.95
0.44
3.0
2.7
—
—
—
0
0
(3003338) MCHC [Mass/volume]
1390
13706
1.05
0.43
26.2
16.8
g/l
331.9
332.6
1.98
1381
13599
(3036489) Thrombin time
68
603
1.13
0.43
2.4
2.2
s
21.4
21.2
0.11
58
535
(3005033) Fetal Nuchal fold Thickness US
42
359
1.17
0.42
1.3
1.4
—
—
—
0
0
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
29
239
1.22
0.42
1.4
1.5
—
—
—
0
0
(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma
12
87
1.38
0.42
1.1
1.2
u/l
14.1
17.5
0.33
12
75
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
1504
14865
1.05
0.41
4.2
3.8
mmol/l
1.3
1.3
0.00
1374
13708
(3047007) Chlamydophila sp Ab [Presence] in Serum
30
249
1.21
0.41
1.1
1.2
—
—
—
0
0
(3038071) Oxygen [Partial pressure] in Mixed venous blood
5
33
1.52
0.41
40.6
6.5
—
—
—
0
0
(3029396) Erythrocyte agglutination [Presence] in Blood
5
33
1.52
0.41
2.8
3.4
—
—
—
0
0
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
187
1996
0.93
0.41
1.8
1.8
%
1.6
1.5
1.22
167
1761
(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
0
15
0.00
0.41
0.0
1.0
—
—
—
0
0
(3017509) Phencyclidine [Presence] in Urine
0
15
0.00
0.41
0.0
1.1
—
—
—
0
0
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
25
304
0.82
0.40
1.4
1.5
—
—
—
0
0
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
11
79
1.39
0.40
1.1
1.4
—
—
—
0
0
(3019174) dRVVT (LA screen)
0
17
0.00
0.40
0.0
1.1
—
—
—
0
0
(4268621)
21
168
1.25
0.40
2.5
2.3
—
—
—
0
0
(3044009) aPTT.lupus sensitive (LA screen)
0
18
0.00
0.40
0.0
1.2
—
—
—
0
0
(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose
0
18
0.00
0.40
0.0
1.3
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
43
371
1.16
0.40
1.4
1.5
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
42
362
1.16
0.39
1.3
1.4
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
283
2692
1.06
0.39
1.5
1.5
—
—
—
0
0
(3014271) Vancomycin [Susceptibility]
10
71
1.41
0.39
3.3
2.8
—
—
—
0
0
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
33
388
0.85
0.38
1.4
1.5
—
—
—
0
0
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
11
80
1.38
0.38
1.1
1.4
—
—
—
0
0
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
128
1185
1.09
0.38
2.5
2.4
ug/l
4.5
7.7
3.82
106
1047
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
41
356
1.15
0.36
2.9
2.4
ug/min
227.1
119.4
0.52
20
220
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
393
3784
1.05
0.35
2.5
2.3
—
—
—
0
0
(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
6
42
1.43
0.35
1.0
1.1
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
1590
15757
1.05
0.35
5.1
4.7
mmol/l
2.8
2.8
0.50
1464
14595
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
18
144
1.25
0.35
2.7
2.6
—
—
—
0
0
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
9
123
0.73
0.35
1.0
1.1
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
50
442
1.13
0.35
1.3
1.4
—
—
—
0
0
(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection
6
43
1.40
0.35
1.5
1.2
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
1531
15163
1.05
0.34
4.7
4.3
mmol/l
5.9
5.9
0.29
1402
13869
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
50
443
1.13
0.34
1.3
1.4
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
58
646
0.89
0.33
2.0
2.1
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
50
444
1.13
0.33
1.3
1.4
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
340
3271
1.05
0.32
4.1
4.1
%
21.4
21.3
0.06
176
1482
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
50
445
1.13
0.32
1.3
1.4
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
191
1810
1.06
0.32
1.9
2.0
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
228
2390
0.95
0.31
3.0
2.9
ug/l
0.7
0.8
0.07
158
1474
(3024932) HLA-DR beta [Type]
7
52
1.35
0.31
1.1
1.1
—
—
—
0
0
(40765089) Chromosome analysis panel - Blood by G-banded
7
55
1.27
0.30
1.1
1.0
—
—
—
0
0
(3000492) Spirometry study
163
1542
1.06
0.29
1.5
1.4
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
181
1719
1.06
0.29
1.6
1.4
—
—
—
0
0
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
59
647
0.91
0.27
2.5
1.7
mg/l
2.6
3.9
0.69
41
457
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
13
104
1.25
0.26
1.4
1.4
—
—
—
0
0
(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum
8
67
1.19
0.26
6.4
2.2
ug/l
15.4
142.8
—
8
57
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
94
877
1.08
0.26
1.9
1.6
—
—
—
0
0
(3016750) Collection duration of Urine
11
86
1.28
0.26
3.6
2.2
min
507.6
498.5
0.15
11
61
(3023430) Cat dander IgE Ab [Units/volume] in Serum
18
214
0.84
0.26
1.0
1.1
u/ml
3.5
5.2
—
9
91
(3047189) Immunofixation for 24 hour Urine
9
72
1.25
0.25
2.1
1.6
—
—
—
0
0
(3039443) Prostate specific Ag panel - Serum or Plasma
24
277
0.86
0.25
1.7
1.6
—
—
—
0
0
(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum
31
273
1.14
0.25
1.4
1.1
iu/ml
245241.2
2110.6
—
9
62
(3008295) Osmolality of Serum or Plasma
21
179
1.18
0.25
1.4
1.5
mosm/kgh2o
281.4
281.1
0.03
15
137
(3003694) ABO and Rh group [Type] in Blood
442
4537
0.97
0.25
1.5
1.5
—
—
—
0
0
(4010399)
116
1095
1.06
0.24
1.5
1.4
—
—
—
0
0
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
32
360
0.89
0.24
1.8
1.7
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
6
83
0.72
0.24
1.2
1.6
—
—
—
0
0
(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum
6
83
0.72
0.24
2.0
2.0
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
6
83
0.72
0.24
1.2
1.6
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
94
882
1.07
0.23
1.1
1.0
—
—
—
0
0
(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood
5
38
1.32
0.23
40.8
6.4
—
—
—
0
0
(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence
5
39
1.28
0.23
1.4
1.1
—
—
—
0
0
(3000034) Microalbumin [Mass/volume] in Urine
16
134
1.20
0.23
1.9
3.2
mg/l
16.2
26.2
—
9
102
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
171
1786
0.95
0.22
1.7
1.7
—
—
—
0
0
(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma
28
247
1.14
0.22
1.4
1.5
nmol/l
0.3
0.3
0.34
21
196
(3001684) Respiratory syncytial virus Ag [Presence] in Specimen
5
40
1.25
0.22
1.4
1.1
—
—
—
0
0
(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma
7
94
0.74
0.22
1.1
1.9
—
—
—
0
0
(3025130) Human papilloma virus identified in Specimen
24
210
1.14
0.21
1.5
1.8
—
—
—
0
0
(3022689) Creatine [Moles/volume] in Urine
5
42
1.19
0.21
1.2
1.6
—
—
—
0
0
(44806420)
5
42
1.19
0.21
2.8
2.6
—
—
—
0
0
(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(3007858) Lactate dehydrogenase 3/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis
0
11
0.00
0.21
0.0
1.0
—
20.4
—
0
11
(3023919) Lactate dehydrogenase 2/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis
0
11
0.00
0.21
0.0
1.0
—
37.5
—
0
11
(3007542) Rye IgE Ab [Units/volume] in Serum
0
11
0.00
0.21
0.0
1.1
—
0.2
—
0
5
(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(3024830) Lactate dehydrogenase 4/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis
0
11
0.00
0.21
0.0
1.0
—
7.4
—
0
11
(3007700) Barley IgE Ab [Units/volume] in Serum
0
10
0.00
0.21
0.0
1.1
—
0.2
—
0
5
(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal
16
135
1.19
0.21
1.5
1.4
mmol/l
12.1
12.6
—
6
30
(3036312) Salmon IgE Ab [Units/volume] in Serum
0
12
0.00
0.21
0.0
1.0
—
0.4
—
0
7
(43055458) Rivaroxaban [Mass/volume] in Serum or Plasma
0
13
0.00
0.21
0.0
1.0
—
219.2
—
0
6
(3014064) Pregnancy associated plasma protein A [Multiple of the median] in Serum or Plasma
0
13
0.00
0.21
0.0
1.0
—
—
—
0
0
(3017446) Testosterone [Moles/volume] in Serum or Plasma
114
1083
1.06
0.20
2.0
2.2
nmol/l
13.6
12.6
0.55
100
967
(3004446) Plasmodium sp identified in Blood by Light microscopy
0
14
0.00
0.20
0.0
2.4
—
—
—
0
0
(40765096) Chromosome analysis panel by Banding
6
48
1.25
0.20
1.2
1.1
—
—
—
0
0
(40768800) Prostate Pathology biopsy report
27
240
1.13
0.20
1.2
1.2
—
—
—
0
0
(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma
16
136
1.18
0.20
1.2
1.0
mg/l
272.6
290.0
0.92
16
119
(3043410) Blood group antigens tested for on Red Blood Cells
6
52
1.15
0.19
2.2
1.3
—
—
—
0
0
(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk
6
53
1.13
0.18
1.0
1.0
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
97
921
1.06
0.18
1.8
1.9
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
26
290
0.90
0.18
1.1
1.1
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
26
290
0.90
0.18
1.2
1.1
—
—
—
0
0
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
52
483
1.08
0.18
1.4
1.5
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
22
195
1.13
0.17
1.0
1.3
—
—
—
0
0
(3014111) Lactate [Moles/volume] in Serum or Plasma
135
1296
1.04
0.17
6.0
7.3
mmol/l
1.3
1.4
0.09
128
1245
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
21
186
1.13
0.17
1.0
1.3
nmol/l
—
—
—
0
0
(3032773) Endomysium IgG Ab [Titer] in Serum
17
148
1.15
0.17
1.2
1.1
—
—
—
0
0
(3011648) Oxygen content in Venous blood
10
120
0.83
0.16
4.3
3.3
%
12.3
10.9
—
10
120
(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection
8
68
1.18
0.16
1.3
1.7
—
1020591.7
—
0
6
(3011288) Drugs identified in Urine by Screen method
44
473
0.93
0.16
3.9
2.8
—
—
—
0
0
(3017315) Amylase [Enzymatic activity/volume] in Urine
6
78
0.77
0.15
1.0
1.2
u/l
384.2
411.4
—
6
70
(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma
9
80
1.13
0.15
1.2
1.2
umol/l
5.5
5.1
—
9
75
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
9
80
1.13
0.15
1.4
1.5
—
—
—
0
0
(3051387) C reactive protein [Mass/volume] in Capillary blood
36
333
1.08
0.14
3.0
3.5
mg/l
20.5
24.6
0.48
24
209
(3038177) Helicobacter pylori Ab [Presence] in Serum
29
266
1.09
0.14
1.1
1.2
—
—
—
0
0
(3020891) Body temperature
54
572
0.94
0.13
6.6
4.7
—
—
—
0
0
(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal
11
94
1.17
0.13
1.5
1.4
—
—
—
0
0
(3026179) Normetanephrine [Moles/volume] in Serum or Plasma
23
209
1.10
0.13
1.0
1.3
nmol/l
0.7
0.6
0.06
23
198
(3013139) Helicobacter pylori Ag [Presence] in Stool
98
1018
0.96
0.12
1.3
1.2
—
—
—
0
0
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
12
104
1.15
0.12
1.9
1.6
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
57
600
0.95
0.12
1.8
1.9
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
29
313
0.93
0.12
1.3
1.2
—
—
—
0
0
(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma
46
434
1.06
0.12
2.0
1.8
nmol/l
42.4
38.6
0.55
46
420
(3000991) Gas panel - Venous blood
130
1261
1.03
0.11
7.8
8.6
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
90
867
1.04
0.11
1.6
1.3
—
—
—
0
0
(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma
12
105
1.14
0.11
1.5
1.5
u/l
2.0
8.1
—
6
48
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
17
186
0.91
0.09
1.0
1.1
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
206
2024
1.02
0.08
2.0
2.1
—
—
—
0
0
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
7
65
1.08
0.08
1.3
1.2
—
—
—
0
0
(40768793) Breast Pathology biopsy report
38
399
0.95
0.08
1.4
1.3
—
—
—
0
0
(3006462) Nitrate [Presence] in Urine
7
67
1.04
0.08
2.9
2.8
—
—
—
0
0
(3025018) Bordetella pertussis Ab [Titer] in Serum
11
98
1.12
0.07
1.1
1.2
—
—
—
0
0
(3045142) Bone marrow Pathology biopsy report
16
174
0.92
0.07
1.7
1.3
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
57
552
1.03
0.06
1.4
1.4
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
67
689
0.97
0.06
1.9
2.1
—
—
—
0
0
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
19
202
0.94
0.05
1.3
1.1
—
—
—
0
0
(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma
12
110
1.09
0.05
1.4
1.4
—
1.4
—
0
7
(4281824)
16
171
0.94
0.05
1.3
1.2
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
68
696
0.98
0.04
1.9
2.1
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
47
456
1.03
0.04
1.1
1.2
—
—
—
0
0
(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma
14
130
1.08
0.04
1.5
1.5
g/l
0.9
1.0
0.70
14
130
(3027008) Opiates [Presence] in Urine
68
695
0.98
0.04
1.9
2.1
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
115
1167
0.98
0.04
1.9
2.0
—
—
—
0
0
(4024509)
13
138
0.94
0.02
1.9
1.4
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
54
549
0.98
0.02
2.1
2.1
—
—
—
0
0
(3020876) Protein [Mass/time] in 24 hour Urine
12
127
0.94
0.01
1.7
2.1
—
1.2
—
0
8
(1002224) Polysomnography panel
66
668
0.99
0.01
1.0
1.1
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
53
537
0.99
0.01
1.5
1.4
—
—
—
0
0
(3000093) Morphology [Interpretation] in Blood Narrative
13
136
0.96
0.00
1.3
1.2
—
—
—
0
0
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
19
195
0.97
0.00
1.1
1.5
—
—
—
0
0
(44813793)
11
114
0.96
0.00
1.1
1.0
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
68
683
1.00
0.00
1.9
2.0
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
84
843
1.00
0.00
1.4
1.5
—
—
—
0
0
(3027318) Ethylene glycol [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3034614) HLA Ag [Interpretation]
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3003157) Bacteria [#/volume] in Mother's milk
0
5
0.00
0.00
0.0
9.0
—
—
—
0
0
(40766799) MGMT gene methylation score in Tissue by Molecular genetics method
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum
0
6
0.00
0.00
0.0
2.0
—
—
—
0
0
(3029612) Listeria sp Ab [Titer] in Serum
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3004347) Hepatitis D virus Ab [Presence] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3007733) Chloride [Moles/volume] in Urine
0
6
0.00
0.00
0.0
1.7
—
54.7
—
0
6
(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3008860) Bordetella pertussis IgM Ab [Presence] in Serum
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum
0
6
0.00
0.00
0.0
2.0
—
—
—
0
0
(3033093) Yersinia sp IgM Ab [Titer] in Serum
0
6
0.00
0.00
0.0
2.0
—
—
—
0
0
(1175825) Sexually transmitted pathogens panel - Specimen by NAA with probe detection
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3044416) Complement C4 [Mass/volume] in Pleural fluid
0
6
0.00
0.00
0.0
1.0
—
0.1
—
0
6
(3012989) Citrate [Moles/time] in 24 hour Urine
0
5
0.00
0.00
0.0
1.6
—
2.9
—
0
5
(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3006653) Thiamine [Moles/volume] in Blood
7
77
0.91
0.00
1.0
1.3
nmol/l
143.9
141.2
—
7
77
(3014114) Aureobasidium pullulans IgG Ab [Mass/volume] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3036525) Urea [Moles/time] in 24 hour Urine
0
8
0.00
0.00
0.0
5.0
—
—
—
0
0
(4211845)
7
73
0.96
0.00
2.9
2.7
—
—
—
0
0
(3037441) Creatinine [Moles/volume] in Peritoneal dialysis fluid
0
7
0.00
0.00
0.0
5.3
—
399.0
—
0
7
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
9
98
0.92
0.00
1.0
1.3
—
—
—
0
0
(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method
0
9
0.00
0.00
0.0
5.7
—
—
—
0
0
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
7
74
0.95
0.00
1.3
1.2
—
—
—
0
0
(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture
7
73
0.96
0.00
1.1
1.1
—
—
—
0
0
(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture
0
9
0.00
0.00
0.0
2.8
—
—
—
0
0
(40758358) Immune stain study
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3040370) OLANZapine [Moles/volume] in Serum or Plasma
6
60
1.00
0.00
2.5
2.1
nmol/l
162.2
142.6
—
6
53
(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.7
—
—
—
0
0
(3022192) Triglyceride [Mass/volume] in Serum or Plasma
5
53
0.94
0.00
5.2
2.2
—
—
—
0
0
(3023511) Choriogonadotropin [Units/volume] in Urine
35
350
1.00
0.00
1.4
1.2
—
—
—
0
0
(21494434) Karyotype in Bone marrow
13
130
1.00
0.00
1.3
1.3
—
—
—
0
0
(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma
0
8
0.00
0.00
0.0
1.4
—
2.6
—
0
8
(40757494) Bilirubin.total [Moles/volume] in Blood
7
79
0.89
0.00
2.3
2.1
—
38.8
—
0
7

Mortality – FinRegistry

↥

Association

Association between endpoint H7_IRIDOCHRONIC and mortality.

Females

Parameter HR [95% CI] p-value
H7_IRIDOCHRONIC 1.199 [1.07, 1.35] 0.002
Birth year 0.997 [0.99, 1.0] 0.405

During the follow-up period (1.1.1998 — 31.12.2019), 840 out of 5935 females with H7_IRIDOCHRONIC died.

Males

Parameter HR [95% CI] p-value
H7_IRIDOCHRONIC 1.122 [0.98, 1.28] 0.086
Birth year 0.985 [0.98, 0.99] 0.002

During the follow-up period (1.1.1998 — 31.12.2019), 650 out of 4335 males with H7_IRIDOCHRONIC died.

Mortality risk

Mortality risk for people of age

years, who have H7_IRIDOCHRONIC.

N-year risk Females Males
1 0.159% 0.214%
5 0.73% 1.147%
10 1.839% 2.968%
15 3.65% 5.763%
20 6.237% 9.782%

Relationships between endpoints

↥

Index endpoint: H7_IRIDOCHRONIC – Chronic iridocyclitis

GWS hits: 1

Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
loading spinner Loading data